Malignant neoplasm of breast, ER-negative, including Hilmo

C3_BREAST_ERNEG_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions not RX_ERPLUS	294747
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C50 Hospital discharge: ICD-9 — 174 Hospital discharge: ICD-8 — 174 Cause of death: ICD-10 — C50 Cause of death: ICD-9 — 174 Cause of death: ICD-8 — 174 Cancer registry: Topography ICD-O-3 — C50 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — [23] 3 out of 7 registries used, show all original rules.	10998
4. Check minimum number of events None	10998
5. Include endpoints None	10998
6. Filter based on genotype QC (FinnGen only)	9893

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE
Control conditions: not RX_ERPLUS

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BREAST_ERNEG_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ERPLUS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS	!RX_ERPLUS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C50
HD_ICD_9	174
HD_ICD_8	174
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C50
COD_ICD_9	174
COD_ICD_8	174
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C50
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	[23]

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of breast, ER-negative, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of breast, HER-negative

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9893	9893	-
Unadjusted period prevalence (%)	3.51	3.51	-
Median age at first event (years)	58.91	58.91	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10227: Matched controls
95633

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A79

ICPC

Malignancy NOS

90.2

323.3

180

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

315.5

309

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

39.1

311.9

201

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

52.7

311.4

188

HAE99

NOMESCO Finland

Other reconstruction of breast

77.9

307.7

408

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

6395.0

307.7

651

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

5.7

307.7

963

1702

WF002

NOMESCO Finland

Radical radiotherapy

49.7

307.7

530

105

A04AA55

ATC

palonosetron, combinations; systemic

6187.2

307.7

1193

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

29.8

307.7

240

ZZF00

NOMESCO Finland

Graft of adipose tissue

33.4

307.7

285

XX3DW

NOMESCO Finland

Time consuming IT work

12.2

307.7

2166

2058

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

19.0

307.7

375

191

HA1HA

NOMESCO Finland

Tomosynthesis mammography

36.1

307.7

234

H02AB02

ATC

dexamethasone; systemic

54.9

307.7

2728

630

HAB99

NOMESCO Finland

Other partial excision of mammary gland

31.0

307.7

1194

406

C50

ICD-10 Finland

Malignant neoplasm of breast

1995.6

307.7

1407

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

397.6

307.7

486

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

342.5

307.7

455

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

307.7

741

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

92.1

307.7

306

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

2999.7

307.7

3121

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

35.8

307.7

232

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

44.6

307.7

274

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1607.5

307.7

918

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

556.7

307.7

1813

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

489

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

53.8

307.7

493

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

138.3

307.7

203

L01BC06

ATC

capecitabine; oral

+∞

307.7

826

A03FA01

ATC

metoclopramide; systemic, rectal

5.6

307.7

3847

9351

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

307.7

376

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

307.7

1178

WZC30

NOMESCO Finland

Teaching

3.2

307.7

2054

6996

PJA12

NOMESCO Finland

Sentinel node biopsy

5017.6

307.7

5106

NK6AN

NOMESCO Finland

Total body bone isotope imaging

57.2

307.7

417

JN4BD

NOMESCO Finland

Extensive body CT

6.3

307.7

1095

1774

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

307.7

857

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

307.7

445

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

307.7

522

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

307.7

1152

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

83.1

307.7

434

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

119.9

307.7

858

A04AA01

ATC

ondansetron; systemic, rectal

7.0

307.7

1299

1953

C50.99

ICD-10 Finland

Breast, unspecified

2474.0

307.7

1842

A04AD12

ATC

aprepitant; systemic

617.9

307.7

504

HAB40

NOMESCO Finland

Wedge excision of mammary gland

201.3

307.7

3587

256

WX402

NOMESCO Finland

General anaesthesia

3.0

307.7

2933

11243

HAC20

NOMESCO Finland

Total mastectomy

1460.1

307.7

2300

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

135.3

307.7

254

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

58.5

307.7

362

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

17.5

307.7

634

359

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

307.7

436

9703

FHL

Breast resection

13.8

307.7

371

261

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

60.2

307.7

402

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

307.7

505

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

307.7

3869

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

307.7

1063

ZX090

NOMESCO Finland

Other technic of radiotherapy

473.5

307.7

663

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

307.7

708

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

25.2

307.7

493

192

WZC00

NOMESCO Finland

Treatment plan or consultation

3.1

307.7

4775

20926

HAD99

NOMESCO Finland

Other plastic operation on breast

30.1

307.7

251

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

6.3

307.7

733

1154

X76

ICPC

Malignant neoplasm breast female

1825.5

307.7

857

WZC15, ,

NOMESCO Finland

55.0

307.7

213

JN4AD

NOMESCO Finland

Body CT examination

4.6

307.7

1166

2623

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

380

ZZR10

NOMESCO Finland

Flap of skin and muscle

94.7

307.7

295

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3811.7

307.7

775

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

934.5

307.7

477

ZX080

NOMESCO Finland

Image guided radiotherapy

1762.5

307.7

564

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

307.7

1514

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

988.5

307.7

2296

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

307.7

378

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

307.7

499

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

122.6

307.7

403

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

35.3

307.7

254

N63

ICD-10 Finland

Unspecified lump in breast

5.7

307.7

1879

3631

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

5427.5

307.7

1521

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

250.5

307.7

436

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

22.6

307.7

2985

1714

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

103.1

307.7

237

A04AA02

ATC

granisetron; systemic, transdermal

354.8

307.7

1322

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

52.3

307.7

346

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

513.4

307.7

715

Z31.5

ICD-10 Finland

Genetic counselling

7.2

307.7

1175

1687

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

569.0

307.7

1184

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

47.3

307.7

218

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

4175.3

307.7

1216

TQB05

NOMESCO Finland

Puncture of skin of trunk

35.4

307.7

262

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

24.9

307.7

250

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

51.6

307.7

662

128

D70.82

ICD-10 Finland

Drug-induced neutropenia

24.8

307.7

256

HA1AA

NOMESCO Finland

X-ray mammography

20.8

307.7

3609

2441

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

39.6

307.7

304

L03AA02

ATC

filgrastim; parenteral

170.0

307.7

452

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

307.7

513

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

9.2

307.7

843

926

L02BA01

ATC

tamoxifen; oral

207.9

307.7

260

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

7.8

307.7

577

729

L03AA13

ATC

pegfilgrastim; parenteral

2221.4

307.7

1313

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

307.7

3746

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

307.7

405

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

66.0

307.7

1504

249

WF049

NOMESCO Finland

Radiotherapy of metastasis

670.3

307.7

347

115

Kela drug reimbursment

Breast cancer

+∞

307.7

3110

XX1XN

NOMESCO Finland

Other isotope examination

1852.7

307.7

400

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.5

307.7

3092

10500

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2120.9

307.7

1071

WF003

NOMESCO Finland

Adjuvant radiotherapy

518.3

307.7

769

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

384.4

307.7

900

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

34.6

307.7

961

286

5702

FHL

Local lymph node removal (eg armpit, groin)

83.4

307.7

184

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

307.7

863

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

307.7

552

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

1185.6

307.7

367

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1995.5

307.7

919

L02BG04

ATC

letrozole; oral

23.1

307.7

639

275

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

106.1

307.7

2495

290

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

486

TQW20

NOMESCO Finland

Tatoe

190.5

307.7

595

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

3646.5

307.7

1693

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

14542.5

307.7

1361

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2797.4

303.8

300

Z51.5

ICD-10 Finland

Palliative care

4.5

296.1

770

1683

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

276.5

271

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

269.3

264

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.5

268.3

546

965

HAD40

NOMESCO Finland

Mastopexy

26.9

267.2

192

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

25.8

263.3

192

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

92.3

263.0

146

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

256.1

4070

23166

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

352.5

251.2

259

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

249.8

245

R4110

NOMESCO Finland

Physiotherapy

2.1

246.0

3260

17281

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

125.0

245.0

132

ZX112

NOMESCO Finland

Subcutaneous

10.9

244.7

274

241

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

59.4

243.7

144

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

47.1

241.3

149

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

390.6

239.6

246

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

79.3

236.9

134

1CD02, ,

NOMESCO Finland

+∞

233.4

229

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

229.3

225

X21

ICPC

Breast sympt/compl female other

5.2

223.7

486

910

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

222.2

218

XX2RW, ,

NOMESCO Finland

12.2

221.3

230

180

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

211.9

208

HAC25

NOMESCO Finland

Radical mastectomy

+∞

209.9

206

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

30.4

204.2

141

WX702

NOMESCO Finland

Supraglottic ventilation device

3.3

199.2

804

2384

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

482.4

199.1

203

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

221.6

197.9

209

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

18.9

197.8

163

HA1S1

NOMESCO Finland

Photography of breasts

102.1

196.5

108

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

101.1

194.5

107

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

192.5

189

HA1SA

NOMESCO Finland

Expansion mammography

38.8

190.5

123

ZX120

NOMESCO Finland

Intravenous

3.0

189.4

942

3158

Z51.0

ICD-10 Finland

Radiotherapy session

308.8

189.0

196

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

42.9

187.2

118

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

1674.6

186.2

185

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.6

182.6

644

1748

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

569.6

177.4

180

FM1FN

NOMESCO Finland

Heart function isotope examination

1758.3

177.0

176

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

176.2

173

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

50.5

175.7

107

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

175.1

172

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

174.1

171

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

172.1

169

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

170.0

167

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

1676.2

169.9

169

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

280.9

168.8

176

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

167.7

2524

13685

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

163.9

161

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

10.5

163.0

186

168

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

394.8

162.7

167

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

43.8

162.5

102

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1583.3

161.7

161

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

181.7

160.9

172

OAA41

NOMESCO Finland

Health check based on individual needs

67.5

160.5

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

1525.9

156.7

156

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

154.7

152

9706

FHL

Ablation mammae, includes axillary exploration

+∞

153.7

151

WF004

NOMESCO Finland

Palliative radiotherapy

254.1

152.7

160

128

Kela drug reimbursment

Cancers of female genital organs

297.4

152.1

158

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.0

150.9

712

2308

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

40.3

146.9

ZXA05

NOMESCO Finland

Left side

1.8

146.4

2768

16052

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

145.5

143

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

145.5

143

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.4

143.4

537

1512

D05.0

ICD-10 Finland

Lobular carcinoma in situ

284.8

143.0

149

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

34.1

140.8

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

138.4

136

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

29.2

137.4

N64.9

ICD-10 Finland

Disorder of breast, unspecified

5.7

136.8

264

442

B01AB05

ATC

enoxaparin; parenteral

1.7

136.7

3293

20436

N64.5

ICD-10 Finland

Other signs and symptoms in breast

3.5

136.5

499

1383

ZX070

NOMESCO Finland

Intensity modified radiotherapy

173.1

136.1

146

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

437.3

135.9

139

ZXA00

NOMESCO Finland

Right side

1.8

135.6

2915

17498

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

135.3

133

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

133.3

131

WW500

NOMESCO Finland

Blood transfusion

4.7

132.3

319

651

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

132.3

130

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

131.3

129

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

131.3

129

X19

ICPC

Breast lump/mass female

4.6

131.0

321

664

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1223.2

129.2

129

YX9AW, ,

NOMESCO Finland

184.1

127.4

136

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

127.2

125

HA1AE, ,

SPAT

3.2

126.7

535

1622

JN4CD

NOMESCO Finland

Very extensive body CT

5.4

124.1

256

456

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

123.9

3942

26194

N02AA05

ATC

oxycodone; systemic

2.0

123.3

1723

8997

HAA10

NOMESCO Finland

Biopsy of mammary gland

6.9

123.0

195

267

D24

ICD-10 Finland

Benign neoplasm of breast

3.9

122.8

384

956

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

16.1

122.8

109

ZZR00

NOMESCO Finland

Flap of skin

10.6

122.8

139

124

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

122.1

120

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

1153.7

122.1

122

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

121.8

4666

32450

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

1144.2

121.0

121

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

6.0

120.9

222

354

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

240.8

120.9

127

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

120.0

118

L01CA04

ATC

vinorelbine; systemic

+∞

120.0

118

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

9.7

119.8

144

140

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

236.8

118.9

125

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

38.2

118.7

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

118.0

116

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

118.0

116

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

118.0

116

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

43.0

115.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.9

115.5

261

504

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

114.9

113

HAD20

NOMESCO Finland

Liposuction of breast

29.0

114.2

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

112.9

111

JN6AD

NOMESCO Finland

CT of torso and neck

9.1

112.2

142

148

X26

ICPC

Fear of breast cancer female

7.5

111.1

164

207

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

110.9

109

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

108.8

107

PJA10

NOMESCO Finland

Exploration of lymph nodes

10.2

107.5

125

116

1XC03, ,

NOMESCO Finland

508.7

106.1

108

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.2

102.5

418

1239

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

+∞

100.7

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

100.7

B01AB10

ATC

tinzaparin; parenteral

2.1

100.1

1054

4946

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

44.9

99.1

HAD00

NOMESCO Finland

Augmentation mammoplasty

44.9

99.1

XX1AD

NOMESCO Finland

Other CT-examination

144.4

98.5

107

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

97.6

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

95.6

9719

FHL

Other measure in this category

17.9

95.0

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

94.6

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.9

92.7

452

1486

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

92.7

464

1548

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

91.9

947

4401

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

+∞

91.5

HA1DA

NOMESCO Finland

Restricted mammography

31.9

89.5

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

50.8

88.5

XX2ET, ,

NOMESCO Finland

+∞

88.4

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

88.4

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

88.4

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

22.5

87.5

1748X

ICD-9 Finland

Malignant neoplasm of female breast, Other specified sites of female breast

+∞

87.4

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

87.4

ZXE00

NOMESCO Finland

One hour or less

1.5

87.3

3758

26218

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

37.6

85.9

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

26.5

85.9

8510/3-C50.9

ICD-O-3

Medullary carcinoma, NOS, of breast, NOS

+∞

85.4

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

22.6

85.1

N60.8

ICD-10 Finland

Other benign mammary dysplasias

7.9

83.7

118

141

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

39.0

83.6

L02BG06

ATC

exemestane; oral

+∞

83.4

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

82.3

XX9TE

NOMESCO Finland

Compementary ultrasound examination

7.4

81.8

122

156

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

+∞

81.3

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.2

80.8

328

969

QBJ00

NOMESCO Finland

Liposuction in trunk

8.1

79.8

110

128

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

262.0

79.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

262.0

79.5

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

79.3

R50.9

ICD-10 Finland

Fever, unspecified

1.8

79.0

1244

6678

G02CX06, ,

ATC

17.7

78.0

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

+∞

77.2

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

77.2

L01XX05

ATC

hydroxycarbamide; oral

20.5

76.7

PJW99

NOMESCO Finland

Other operation on lymphatic system

365.3

75.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

75.4

4086

29645

9702

FHL

Breast exploration and possible tumor removal

3.4

75.2

279

779

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.8

75.0

240

607

A04AA03

ATC

tropisetron; systemic

37.6

73.5

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

242.3

73.5

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

242.3

73.5

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

73.2

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

73.2

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.2

72.7

198

445

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

6.7

72.6

119

169

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

8.9

72.4

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

72.3

875

4299

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.9

71.9

162

312

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

20.6

71.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

71.5

1041

5442

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

71.1

N05CB02

ATC

barbiturates in combination with other drugs

2.6

71.0

427

1566

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

70.8

1073

5680

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

36.0

69.7

HA4BT

NOMESCO Finland

Breast seed implant placement under ultrasound guidance

174.2

69.2

XX2VW

NOMESCO Finland

Radiologic consultation

6.9

68.9

109

149

QBA00

NOMESCO Finland

Puncture of skin of trunk

10.8

68.3

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

68.1

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

16.8

68.0

Z3231

NOMESCO Finland

Registered nurse

1.5

66.6

2430

16154

8140/3-C50.9

ICD-O-3

Adenocarcinoma, NOS, of breast, NOS

+∞

66.1

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

66.0

542

2292

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

27.6

65.9

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

216.5

65.5

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

610.3

64.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

64.0

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

63.0

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

591.4

62.3

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

23.2

62.1

17409

ICD-8 Finland

Malignant neoplasm of breast, Unspecified

+∞

62.0

9724

FHL

Breast augmentation or reconstruction with own tissue

24.0

61.5

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.7

60.1

194

494

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

8.1

60.0

WB321

NOMESCO Finland

Multiple adjuvant therapy of malignancy with biomodifiers

+∞

59.9

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

8.4

58.8

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

58.0

1895

12245

1743A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-inner quadrant

+∞

57.9

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

+∞

57.9

S77

ICPC

Malignant neoplasm of skin

13.5

57.6

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

543.9

57.2

1741A

ICD-9 Finland

Malignant neoplasm of female breast, Central portion

+∞

56.9

ZSZ00

NOMESCO Finland

Primary repair operation

274.5

55.8

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

185.0

55.5

S18

ICPC

Laceration/cut

1.4

55.4

4399

33596

A02BC02

ATC

pantoprazole; systemic

1.4

55.4

7039

58180

C56

ICD-10 Finland

Malignant neoplasm of ovary

114.8

55.2

Z3226

NOMESCO Finland

Physiotherapist

1.6

55.1

1676

10643

N61

ICD-10 Finland

Inflammatory disorders of breast

2.9

55.1

275

915

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.3

54.4

145

321

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

515.5

54.2

HA1BA

NOMESCO Finland

Extensive X-ray mammography

6.7

54.1

124

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

53.8

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

53.8

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

7.3

53.7

105

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

52.8

D05

ICD-10 Finland

Carcinoma in situ of breast

+∞

52.8

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

12.4

52.8

2393A

ICD-9 Finland

Neoplasm of unspecified nature, Breast

5.6

52.1

101

170

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

51.8

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

254.8

51.8

N02BE01

ATC

paracetamol; systemic, rectal

1.7

51.4

9199

80592

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

50.8

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

50.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

50.7

755

3958

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

68.3

49.5

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.4

49.5

124

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

49.5

871

4802

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

240.0

48.8

N62

ICD-10 Finland

Hypertrophy of breast

2.1

47.8

501

2330

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

47.7

3AA13, ,

NOMESCO Finland

+∞

47.7

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

47.7

JAL30

NOMESCO Finland

Omentectomy

5.6

47.1

156

HA1AT, ,

SPAT

9.1

46.9

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.9

46.9

624

3155

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

46.8

279

1018

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

46.7

8000/3-C50.9

ICD-O-3

Neoplasm, malignant of breast, NOS

+∞

46.7

Z31.6

ICD-10 Finland

General counselling and advice on procreation

7.7

46.7

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.2

46.6

126

282

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

46.1

465

2131

WX704

NOMESCO Finland

Intubation

1.8

45.9

720

3833

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

12.7

45.7

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

45.1

339

1378

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

4.9

45.0

102

198

D45

ICD-10 Finland

Polycythaemia vera

13.9

44.9

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

44.7

N06AX16

ATC

venlafaxine; oral

1.5

44.4

1391

8854

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

44.3

571

2856

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

+∞

43.7

L57.0

ICD-10 Finland

Actinic keratosis

1.7

42.7

900

5205

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

42.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.5

42.6

288

1117

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.6

42.2

C20

ICD-10 Finland

Malignant neoplasm of rectum

401.8

42.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

42.0

732

4018

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

41.6

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

41.6

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

6.2

41.0

107

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

40.9

342

1456

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

40.6

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

40.6

DHB00

NOMESCO Finland

Excision of lesion of external nose

8.2

40.4

N64.8

ICD-10 Finland

Other specified disorders of breast

4.3

39.8

105

231

C90.0

ICD-10 Finland

Multiple myeloma

134.6

39.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

39.6

6663

55796

C82.1

ICD-10 Finland

Follicular lymphoma grade II

373.4

39.1

ZX092, ,

NOMESCO Finland

373.4

39.1

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

373.4

39.1

J01MA12

ATC

levofloxacin; systemic

1.5

38.9

1468

9697

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

192.4

38.8

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.9

38.6

114

273

C50.0

ICD-10 Finland

Malignant neoplasm: Nipple and areola

+∞

38.6

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

38.4

501

2515

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

38.2

192

642

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

7.2

38.1

L02BG03

ATC

anastrozole; oral

60.3

37.9

156

Kela drug reimbursment

Lapatinib

+∞

37.6

R18

ICD-10 Finland

Ascites

3.6

37.2

125

328

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

354.5

37.0

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

354.5

37.0

WF099

NOMESCO Finland

Other radiotherapy

9.2

36.9

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

36.8

459

2268

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

6.4

36.8

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

36.6

XW000

NOMESCO Finland

Bone marrow biopsy

2.7

36.5

208

743

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

345.0

36.0

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

65.6

35.8

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

35.5

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

35.5

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

35.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

35.5

9721

FHL

Mamilla reconstruction or transposition

45.9

35.4

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

335.5

35.0

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

8.8

35.0

B29

ICPC

Lymph/immune mech sympt/complt other

6.3

34.8

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

34.6

1916

13552

8500/2-C50.5

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast

+∞

34.5

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

34.5

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.9

34.5

104

253

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.0

34.3

155

489

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.6

34.1

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

43.8

33.6

1740A

ICD-9 Finland

Malignant neoplasm of female breast, Nipple and areola

+∞

33.5

L02AE02

ATC

leuprorelin; implant, parenteral

3.7

33.5

109

280

SPAT1324

SPAT

Screening procedure

0.7

33.5

1140

15028

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

33.1

594

3283

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.4

33.1

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

33.1

712

4133

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

33.0

156

505

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

32.9

254

1046

JFB30

NOMESCO Finland

Right hemicolectomy

5.0

32.9

136

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.4

32.5

221

860

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

32.5

SPAT1269

SPAT

Other puncture and/or drainage

5.7

32.1

101

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

307.1

32.0

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

31.8

195

723

L01XE07

ATC

[U] lapatinib

+∞

31.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

31.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

31.5

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

31.5

8211/3-C50.4

ICD-O-3

Tubular adenocarcinoma of upper-outer quadrant of breast

+∞

31.5

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

31.5

J01DB01

ATC

cefalexin; oral

1.3

31.3

7918

68804

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

31.1

729

4321

HAB20

NOMESCO Finland

Excision of lactiferous duct

5.4

31.0

108

D75

ICPC

Malignant neoplasm colon/rectum

12.6

30.6

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

30.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

30.5

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

30.2

243

1018

Z2221

NOMESCO Finland

Medical doctor

1.3

29.5

2342

17460

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

29.5

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

29.5

1XC13, ,

NOMESCO Finland

+∞

29.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

29.5

M05BX04

ATC

denosumab; parenteral

1.6

29.4

675

3979

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

29.4

512

2806

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

7.5

29.3

A46

ICD-10 Finland

Erysipelas

1.5

29.2

1167

7764

ZSZ10

NOMESCO Finland

Secondary repair operation

54.7

29.2

KCD02

NOMESCO Finland

Transurethral resection of bladder

6.3

29.1

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

29.0

187

710

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

283.5

29.0

9708

FHL

Radical mastectomy (Halsted), also involves removal of the parasternal gland

283.5

29.0

TPX15

NOMESCO Finland

Removal of vascular injection port

8.9

29.0

ZX050

NOMESCO Finland

Stereotactic radiotherapy

10.0

28.9

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

28.9

174

640

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.6

28.9

255

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

3.8

28.7

221

N05CF01

ATC

zopiclone; oral

1.3

28.6

3162

24637

PJ5YQ, ,

NOMESCO Finland

+∞

28.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

28.4

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

28.4

M05BA02

ATC

clodronic acid; systemic

29.7

28.0

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

273.7

28.0

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

6.9

27.9

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.9

27.7

197

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

27.7

970

6287

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

27.6

411

2151

A06AH03

ATC

naloxegol; oral

4.4

27.5

150

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

+∞

27.4

PJ2D3

NOMESCO Finland

Histological assessment of lymph node

+∞

27.4

C49.39

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor

+∞

27.4

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

27.4

8401/3-C50.9

ICD-O-3

Apocrine adenocarcinoma of breast, NOS

+∞

27.4

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

27.4

C50.61

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, ductal tumor

+∞

27.4

8500/2-C50.3

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast

+∞

27.4

8500/2-C50.2

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast

+∞

27.4

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

33.8

27.4

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.0

27.3

123

388

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

5.3

26.8

X77

ICPC

Malignant neopl genital female other

39.8

26.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

26.4

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

26.4

8575/3-C50.9

ICD-O-3

Metaplastic carcinoma, NOS, of breast, NOS

+∞

26.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

26.4

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

26.2

762

4746

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

254.1

26.0

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

131.3

25.9

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

10.0

25.6

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

+∞

25.4

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

25.4

8543/3-C50.9

ICD-O-3

Paget disease and intraductal carcinoma of breast of breast, NOS

+∞

25.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

25.4

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

25.4

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

25.4

C507, ,

ICD-10 Finland

+∞

25.4

L01EF03

ATC

abemaciclib; oral

+∞

25.4

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

25.4

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

25.4

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

25.4

THA00

NOMESCO Finland

Needle biopsy of mamilla

8.0

25.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

25.3

602

3581

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.5

25.2

233

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

24.1

25.2

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.1

25.0

106

323

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

68.1

25.0

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

37.5

25.0

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

24.8

166

643

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

24.7

326

1642

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

24.6

318

1591

HA5CB

NOMESCO Finland

Galactography

5.6

24.4

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

24.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

24.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

24.4

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

+∞

24.4

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

24.4

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

33.3

24.3

HA1AA, ,

SPAT

1.8

24.2

346

1788

ZQZ00

NOMESCO Finland

Treatment of several skin areas

7.3

24.2

HA1RA, ,

SPAT

1.6

24.1

608

3664

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

234.6

24.0

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

234.6

24.0

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

121.9

23.9

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

5.9

23.8

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.4

23.7

169

674

ZXC96

NOMESCO Finland

Robot assisted procedure

3.5

23.6

212

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

23.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

23.4

L01CB01

ATC

etoposide; systemic

+∞

23.4

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

23.4

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

23.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

23.4

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

23.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

23.4

A21

ICPC

Risk factor for malignancy

27.3

23.2

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

35.2

23.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

23.1

601

3650

QBA10

NOMESCO Finland

Incision of skin of trunk

3.4

23.0

229

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

224.9

23.0

L03AB05

ATC

interferon alfa-2b; parenteral

224.9

23.0

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

224.9

23.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

22.8

319

1638

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

22.8

268

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

9.7

22.6

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

43.7

22.6

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

22.5

231

1068

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

22.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

22.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

22.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.4

22.2

230

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

22.0

161

649

L01AX03

ATC

temozolomide; systemic

215.5

22.0

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

4.4

21.7

118

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.7

21.6

972

12293

9729

FHL

Other measure in this category

4.8

21.5

ZZA50

NOMESCO Finland

Full thickness skin graft

8.2

21.4

R84

ICPC

Malignant neoplasm bronchus/lung

48.7

21.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

21.3

9020/3-C50.9

ICD-O-3

Phyllodes tumor, malignant of breast, NOS

+∞

21.3

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

21.3

8575/3-C50.4

ICD-O-3

Metaplastic carcinoma, NOS, of upper-outer quadrant of breast

+∞

21.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

21.3

JAL00

NOMESCO Finland

Biopsy of peritoneum

5.3

21.2

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.6

21.0

127

469

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

206.1

21.0

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

206.1

21.0

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.2

20.7

250

ZX121

NOMESCO Finland

Central venous catheter

9.0

20.6

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.4

20.6

137

530

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.1

20.6

127

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

24.7

20.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

20.4

437

2531

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

+∞

20.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

20.3

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

+∞

20.3

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

20.3

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

20.3

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.1

20.2

205

944

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

2.7

20.2

105

360

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

196.8

20.0

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

103.1

20.0

X18

ICPC

Breast pain female

2.1

19.9

186

830

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

19.9

6306

63366

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

39.0

19.8

HAB30

NOMESCO Finland

Excision of mamilla or areola

18.8

19.6

L02AB02

ATC

medroxyprogesterone; systemic

3.7

19.4

158

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

25.3

19.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

19.3

8504/2-C50.9

ICD-O-3

Encapsulated papillary carcinoma of breast, NOS

+∞

19.3

8401/3-C50.4

ICD-O-3

Apocrine adenocarcinoma of upper-outer quadrant of breast

+∞

19.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

19.3

335

Kela drug reimbursment

Lapatinib

+∞

19.3

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

19.3

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

19.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

19.3

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

19.1

414

2405

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

68.8

19.1

HA1HA, ,

SPAT

6.2

19.0

153

Kela drug reimbursment

Lenalidomid

187.4

19.0

ZZS55

NOMESCO Finland

Distension of tissue expander

98.4

19.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

18.9

500

3049

X79

ICPC

Benign neoplasm breast female

15.3

18.8

2170A

ICD-9 Finland

Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]

2.9

18.5

277

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

18.5

173

774

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.9

18.4

273

A08

ICPC

Swelling

1.5

18.4

550

3445

ZZR70

NOMESCO Finland

Perforator flaps

51.5

18.3

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

18.3

1854

14155

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.4

18.3

122

473

1511

Kela drug reimbursment

Olaparib

+∞

18.3

8530/3-C50.9

ICD-O-3

Inflammatory carcinoma of breast, NOS

+∞

18.3

8523/3-C50.4

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast

+∞

18.3

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

18.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

18.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

18.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

18.3

8211/3-C50.2

ICD-O-3

Tubular adenocarcinoma of upper-inner quadrant of breast

+∞

18.3

389

Kela drug reimbursment

Olaparib

+∞

18.3

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

32.1

18.2

B01AB04

ATC

dalteparin; parenteral

1.6

18.1

384

2220

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

178.0

18.0

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

178.0

18.0

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

93.7

18.0

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

93.7

18.0

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.1

17.8

112

XX2XW

NOMESCO Finland

Other teleradiological consultation

4.2

17.8

108

QCJ00

NOMESCO Finland

Liposuction in upper limb

20.3

17.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

17.5

711

4732

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

49.2

17.4

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.9

17.3

273

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

17.3

8543/3-C50.1

ICD-O-3

Paget disease and intraductal carcinoma of breast of central portion of breast

+∞

17.3

C50.02

ICD-10 Finland

Malignant tumor of nipple and areola, lobular tumor

+∞

17.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

17.3

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

17.3

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

17.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

17.3

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

17.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

17.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

17.3

1CD01, ,

NOMESCO Finland

+∞

17.3

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

62.4

17.2

ZZS50

NOMESCO Finland

Insertion of tissue expander

89.0

17.1

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

168.6

17.0

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

168.6

17.0

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

168.6

17.0

L04AX04

ATC

lenalidomide; oral

168.6

17.0

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

168.6

17.0

D77

ICPC

Malignant digestive neopl other/NOS

34.4

17.0

WPA13

NOMESCO Finland

Palliative consultation

5.3

16.8

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

16.8

406

2423

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

5.6

16.6

WPB10

NOMESCO Finland

Making a convalescent care decision

6.8

16.3

8500/2-C50.1

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast

+∞

16.2

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

16.2

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

16.2

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

16.2

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

+∞

16.2

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

16.2

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

16.2

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

16.2

1357

10097

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

59.3

16.2

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

5.2

16.1

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

84.4

16.1

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

159.2

16.0

N02AA01

ATC

morphine; systemic, rectal

2.5

16.0

103

394

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.2

15.8

129

547

GDC00

NOMESCO Finland

Lobectomy of lung

16.7

15.8

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.2

15.6

137

599

ZZA00

NOMESCO Finland

Split skin graft

2.1

15.5

150

681

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

15.6

15.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

15.4

374

2236

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

15.2

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

15.2

8510/3-C50.4

ICD-O-3

Medullary carcinoma, NOS, of upper-outer quadrant of breast

+∞

15.2

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

15.2

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

15.2

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

15.2

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

15.2

HA1UA

NOMESCO Finland

Contrast-enhanced X-ray of the mammary gland

79.7

15.1

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

79.7

15.1

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

79.7

15.1

N05BA04

ATC

oxazepam; oral

1.2

15.1

2491

20012

329

Kela drug reimbursment

Lenalidomide

149.8

15.1

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

149.8

15.1

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

149.8

15.1

E0000UV, ,

ATC

1.2

14.9

3848

32211

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

14.8

1511

17154

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

14.7

132

583

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.7

14.6

277

JAH00

NOMESCO Finland

Laparotomy

2.0

14.6

156

734

SPAT1153

SPAT

Removal of sutures

1.2

14.6

2548

20567

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.8

14.6

1358

15591

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

14.4

467

6280

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

6.7

14.4

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

1.9

14.4

184

922

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

14.4

1014

7370

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

4.0

14.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

14.2

2766

22545

N60.0

ICD-10 Finland

Solitary cyst of breast

2.6

14.2

292

8540/3-C50.0

ICD-O-3

Paget disease, mammary of nipple

+∞

14.2

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

14.2

8500/2-C50.8

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast

+∞

14.2

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

14.2

8503/2-C50.4

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast

+∞

14.2

1744A, ,

ICD-10 Finland

+∞

14.2

L01XK01

ATC

olaparib; oral

+∞

14.2

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

14.2

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

14.2

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

14.2

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

14.2

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

14.2

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

14.2

1XC14, ,

NOMESCO Finland

+∞

14.2

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

+∞

14.2

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

14.2

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

1.6

14.2

301

1743

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

75.0

14.1

HAC99

NOMESCO Finland

Other mastectomy

75.0

14.1

9722

FHL

Reduction plastic and possible mamilla transposition

3.7

14.1

111

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

140.5

14.1

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.0

13.8

182

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

13.8

554

3678

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.3

13.8

100

404

3090, ,

Kela drug reimbursment

14.4

13.8

A10BA02

ATC

metformin; oral

0.8

13.7

1665

18573

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

17.9

13.7

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

39.8

13.6

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

10.6

13.6

T90

ICPC

Diabetes non-insulin dependent

0.8

13.5

1412

16011

WX707

NOMESCO Finland

Fiberoscopic intubation

5.5

13.5

ZXA10

NOMESCO Finland

Bilateral

1.2

13.5

1675

13048

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

28.1

13.4

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

5.7

13.4

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

13.4

917

6636

GA5AA

NOMESCO Finland

Rib X-ray examination

4.5

13.3

E66.01

ICD-10 Finland

Obesity due to excess calories

0.7

13.2

433

5814

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

13.2

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

13.2

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

+∞

13.2

1515, ,

Kela drug reimbursment

+∞

13.2

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

13.2

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

13.2

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

13.2

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

13.2

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

13.2

1501

Kela drug reimbursment

Palbociclib

+∞

13.2

C49.30

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax without histology

+∞

13.2

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

13.2

C50.69

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, other or undeterminated histology

+∞

13.2

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

13.2

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

13.2

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

13.2

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

13.2

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

13.2

8522/3-C50.5

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast

+∞

13.2

PJA13, ,

NOMESCO Finland

+∞

13.2

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

13.2

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

13.2

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

13.2

3030

Kela drug reimbursment

Abemaciclib

+∞

13.2

394

Kela drug reimbursment

Palbociclib

+∞

13.2

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

13.2

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

13.2

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

70.3

13.2

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.1

13.2

124

558

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

131.1

13.1

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

131.1

13.1

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

131.1

13.1

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

31.8

13.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

13.0

1879

14865

R06AE07

ATC

cetirizine; oral

1.2

13.0

4248

36126

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.7

12.8

257

1467

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

19.8

12.8

SAA01

NOMESCO Finland

Simple examination of mouth

0.9

12.6

5950

59181

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.4

12.5

125

JG1BG

NOMESCO Finland

MRI of rectum

11.3

12.5

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

15.6

12.5

A26

ICPC

Fear of cancer, NOS

3.0

12.4

174

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.5

12.4

274

HAD35

NOMESCO Finland

Reduction mammoplasty with transplantation of areola

4.8

12.4

JFF23

NOMESCO Finland

Transversostomy

3.9

12.3

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.2

12.2

141

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

65.7

12.2

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

65.7

12.2

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

12.2

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

12.2

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

12.2

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

12.2

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

12.2

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

12.2

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

12.2

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

12.2

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

12.2

Z44.3

ICD-10 Finland

Fitting and adjustment of external breast prosthesis

+∞

12.2

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

12.2

8509/2-C50.9

ICD-O-3

Solid papillary carcinoma in situ of breast, NOS

+∞

12.2

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

12.2

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

12.2

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

12.2

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

12.2

Z2446

NOMESCO Finland

Social worker

1.5

12.2

385

2442

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

121.7

12.1

ZX095

NOMESCO Finland

Combined chemoradiotherapy

121.7

12.1

HA4RT

NOMESCO Finland

Breast seed implant placement under stereotactic guidance

121.7

12.1

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

121.7

12.1

WW200, ,

SPAT

0.8

12.0

2289

24500

C44

ICD-10 Finland

Other malignant neoplasms of skin

11.5

12.0

S04

ICPC

Lump/swelling localized

1.3

11.9

904

6635

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

11.8

385

2458

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.0

11.7

124

583

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

11.7

1773

14075

QBB10, ,

SPAT

2.1

11.7

113

515

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.2

11.6

136

WZC00, ,

SPAT

0.8

11.6

900

10587

9705

FHL

Subcutaneous mastectomy

16.9

11.6

ZXC82

NOMESCO Finland

Microsurgical

16.9

11.6

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

19.9

11.6

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

19.9

11.6

E34.0

ICD-10 Finland

Carcinoid syndrome

43.7

11.5

SPAT1152

SPAT

Removal of foreign body from under the skin

1.7

11.5

192

1045

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.8

11.5

187

-1, ,

ICD-10 Finland

1.5

11.5

320

1978

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

5.1

11.4

SAA02

NOMESCO Finland

Basic examination of mouth

0.9

11.3

5379

53718

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

11.3

582

4034

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

13.7

11.3

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

28.1

11.2

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

3.9

11.2

WX002

NOMESCO Finland

Sedation and analgesia

1.2

11.2

1583

12477

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

11.2

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

+∞

11.2

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

11.2

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

+∞

11.2

C739, ,

ICD-10 Finland

+∞

11.2

ZZQ60

NOMESCO Finland

Free microvascular graft of nerve

+∞

11.2

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

11.2

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

11.2

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

11.2

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

11.2

9120/3-C50.9

ICD-O-3

Hemangiosarcoma of breast, NOS

+∞

11.2

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

11.2

8097/3-C44.5

ICD-O-3

Basal cell carcinoma, nodular of skin of trunk

+∞

11.2

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

11.2

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

11.2

JFF10

NOMESCO Finland

Loop enterostomy

4.4

11.2

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

11.7

11.1

9710

FHL

Existence of a relapse

112.4

11.1

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

112.4

11.1

J05AB11

ATC

valaciclovir; oral

1.2

11.0

1301

10064

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

11.0

246

1447

A14AB01

ATC

nandrolone; parenteral

4.4

11.0

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

32.8

10.9

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

10.9

332

2093

EBA00

NOMESCO Finland

Extraction of tooth

0.8

10.8

2311

24535

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.3

10.7

346

TJF80

NOMESCO Finland

Ostomy education

3.1

10.7

133

H01CB03

ATC

lanreotide; parenteral

15.9

10.7

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

9.8

10.7

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

4.1

10.7

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

4.8

10.6

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

2.8

10.6

174

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

2.8

10.6

169

A02BC05

ATC

esomeprazole; systemic

1.2

10.6

3910

33389

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

10.6

572

3996

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.3

10.5

314

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.7

10.5

169

912

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

10.4

115

550

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

2.6

10.4

208

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.2

10.4

351

ZXC50

NOMESCO Finland

Cryotherapy

1.8

10.4

165

887

2506

FHL

Thyroidectomy

5.5

10.3

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

16.6

10.3

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

56.2

10.3

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

56.2

10.3

ZXD20

NOMESCO Finland

Day surgery

1.3

10.2

1058

8065

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

2.8

10.2

168

OAB42, ,

SPAT

0.8

10.2

705

8419

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

10.2

8524/3-C50.9

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of breast, NOS

+∞

10.2

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

10.2

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

10.2

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

+∞

10.2

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

10.2

8522/3-C50.2

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast

+∞

10.2

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

10.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

10.2

C80.9

ICD-10 Finland

Malignant neoplasm, primary site unspecified

+∞

10.2

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

10.2

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

10.2

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

10.2

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

+∞

10.2

L01EH01

ATC

lapatinib; oral

+∞

10.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

10.2

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

10.2

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

10.2

8520/3-C50.3

ICD-O-3

Lobular carcinoma, NOS, of lower-inner quadrant of breast

+∞

10.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

10.2

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

10.2

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

10.2

1BC02, ,

NOMESCO Finland

+∞

10.2

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

10.2

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

10.2

180

Kela drug reimbursment

Interferon alfa

+∞

10.2

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

10.2

9829

FHL

Other measure in this category

103.0

10.1

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

103.0

10.1

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.3

10.1

308

H01CB02

ATC

octreotide; parenteral

10.5

10.1

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

10.1

195

1107

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.5

10.0

240

A98

ICPC

Health maint/preventive medicine

0.8

10.0

9387

89391

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

9.9

5285

52618

C03CA01

ATC

furosemide; systemic

1.2

9.9

2553

21197

ZXD05

NOMESCO Finland

Urgent procedure

1.2

9.8

2165

17750

SFA10

NOMESCO Finland

One-surface restoration

0.9

9.8

4255

42952

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.8

9.8

1436

15776

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.8

9.7

133

684

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.3

9.7

273

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

37.4

9.6

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

9.6

877

6582

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

4.9

9.6

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

10.5

9.6

N02AX02

ATC

tramadol; systemic, rectal

1.1

9.6

3657

31236

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

9.6

1053

8078

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

7.9

9.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

9.5

1151

8919

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.0

9.5

427

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

15.6

9.5

SFA20

NOMESCO Finland

Two-surface restoration

0.9

9.5

4578

45934

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

4.1

9.5

D76

ICPC

Malignant neoplasm pancreas

51.5

9.4

K02.1

ICD-10 Finland

Caries of dentine

0.9

9.4

4393

44177

A07AA02

ATC

nystatin; oral

1.3

9.3

515

3615

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

9.2

693

5077

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.8

9.2

129

669

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.6

9.2

192

1112

A87

ICPC

Complication of medical treatment

2.5

9.2

222

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

93.6

9.2

HA1DT

NOMESCO Finland

Mammary gland biopsy with MRI guidance

93.6

9.2

ZX004, ,

NOMESCO Finland

93.6

9.2

8520/2-C50.4

ICD-O-3

Lobular carcinoma in situ, NOS, of upper-outer quadrant of breast

+∞

9.1

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

9.1

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

+∞

9.1

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

9.1

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

9.1

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

9.1

4CJ01, ,

NOMESCO Finland

+∞

9.1

C51.01

ICD-10 Finland

Squamous cell carcinoma of the labium majus

+∞

9.1

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

+∞

9.1

8541/3-C50.9

ICD-O-3

Paget disease and infiltrating duct carcinoma of breast of breast, NOS

+∞

9.1

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

9.1

8507/3-C50.9

ICD-O-3

Invasive micropapillary carcinoma of breast of breast, NOS

+∞

9.1

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

9.1

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

9.1

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

9.1

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

+∞

9.1

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

9.1

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

9.1

8503/3-C50.9

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of breast, NOS

+∞

9.1

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

9.1

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

9.1

1746A

ICD-9 Finland

Malignant neoplasm of female breast, Axillary tail

+∞

9.1

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

9.1

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

+∞

9.1

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

+∞

9.1

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

9.1

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

9.1

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

3.6

9.1

JJB10

NOMESCO Finland

Atypcal resection of liver

20.3

9.0

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

9.0

313

2029

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.4

9.0

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

1.9

9.0

106

521

B03XA02

ATC

darbepoetin alfa; parenteral

2.1

8.9

349

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

11.5

8.9

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.0

8.9

118

21899

ICD-8 Finland

Uterine fibroma

1.4

8.9

486

3404

L03.3

ICD-10 Finland

Cellulitis of trunk

2.4

8.8

243

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.9

8.8

134

X20

ICPC

Nipple symptom/complaint female

2.9

8.8

124

HAA00

NOMESCO Finland

Incision of mammary gland

4.9

8.8

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.5

8.7

N60.2

ICD-10 Finland

Fibroadenosis of breast

2.2

8.7

298

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.2

8.7

292

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.9

8.7

3479

35412

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

4.7

8.7

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.4

8.7

336

2223

KAC10

NOMESCO Finland

Total nephrectomy with capsule

7.2

8.6

PD2BD

NOMESCO Finland

Extensive CT angiography of pelvic organs

17.4

8.6

ZXM40

NOMESCO Finland

Use of fluorescent substance

8.4

8.6

9734

FHL

Excision and local plastic or associated free skin grafting

2.6

8.6

168

OAB47, ,

SPAT

0.7

8.5

232

3225

KMAK, ,

NOMESCO Finland

0.9

8.5

3792

38356

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

1.6

8.5

193

1141

L02AE03

ATC

goserelin; implant

2.4

8.5

207

SFA30

NOMESCO Finland

Three-surface restoration

0.9

8.5

3207

32783

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

8.5

373

2524

ZXC15

NOMESCO Finland

Use of photodynamic technique

2.4

8.4

208

HAA01

NOMESCO Finland

Suture of mammary gland

46.8

8.4

WE198

NOMESCO Finland

Palliative cystotatic therapy

46.8

8.4

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

46.8

8.4

WE100

NOMESCO Finland

Profylactic cytostatic therapy

46.8

8.4

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

8.4

1272

13949

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.5

8.3

S29

ICPC

Skin symptom/complaint other

1.2

8.2

1739

14186

TQX05

NOMESCO Finland

Skin puncture, unspecified location

4.0

8.2

L58.9

ICD-10 Finland

Radiodermatitis, unspecified

25.7

8.2

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

25.7

8.2

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.3

8.2

PJW20

NOMESCO Finland

Lymphovenous shunt

84.3

8.2

189

Kela drug reimbursment

Imatinib

84.3

8.2

9822

FHL

Myocutaneous graft

84.3

8.2

9844

FHL

Musculocutaneous tongue

84.3

8.2

HA1TA

NOMESCO Finland

Extensive combined assessment of mammary gland (mammography, ultrasound and sampling)

84.3

8.2

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

84.3

8.2

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

84.3

8.2

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

84.3

8.2

NK6SN

NOMESCO Finland

Bone SPECT

18.7

8.2

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

18.7

8.2

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.7

8.1

129

695

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

8.1

711

8256

A10BK01

ATC

dapagliflozin; oral

0.7

8.1

315

4101

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

8.1

1DB03, ,

NOMESCO Finland

+∞

8.1

1XC07, ,

NOMESCO Finland

+∞

8.1

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

+∞

8.1

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

8.1

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

8.1

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

8.1

L01BC59

ATC

trifluridine, combinations; systemic

+∞

8.1

369

Kela drug reimbursment

Regorafenib

+∞

8.1

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

8.1

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

+∞

8.1

8501/2-C50.9

ICD-O-3

Comedocarcinoma, noninfiltrating of breast, NOS

+∞

8.1

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

8.1

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

8.1

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

8.1

L01EF02

ATC

ribociclib; oral

+∞

8.1

17401

ICD-8 Finland

Malignant neoplasm of breast, Cutis

+∞

8.1

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

8.1

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

8.1

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

8.1

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

8.1

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

8.1

C53.0

ICD-10 Finland

Malignant neoplasm: Endocervix

+∞

8.1

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

8.1

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

8.1

159

Kela drug reimbursment

Pazopanib

+∞

8.1

176

Kela drug reimbursment

Regorafenib

+∞

8.1

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

+∞

8.1

8211/3-C50.5

ICD-O-3

Tubular adenocarcinoma of lower-outer quadrant of breast

+∞

8.1

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

8.1

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

8.1

L01EF01

ATC

palbociclib; oral

+∞

8.1

C49.19

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor

+∞

8.1

8480/3-C50.2

ICD-O-3

Mucinous adenocarcinoma of upper-inner quadrant of breast

+∞

8.1

L01XE01

ATC

[U] imatinib

+∞

8.1

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

+∞

8.1

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

2.9

8.1

120

J01FF01

ATC

clindamycin; systemic

1.2

8.1

2187

18184

L91.0

ICD-10 Finland

Hypertrophic scar

2.0

8.1

389

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.9

8.1

1838

19491

A02BA02

ATC

ranitidine; systemic

1.2

8.0

1672

13624

G03CA04

ATC

estriol; systemic, vaginal

1.2

8.0

888

6817

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

6.8

8.0

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.1

8.0

334

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.7

8.0

150

848

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.7

7.9

259

3475

SPAT1193

SPAT

Pap smear

0.8

7.9

496

6006

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.8

7.9

1457

15720

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.7

7.9

389

4871

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

1.9

7.9

478

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

1.9

7.8

439

G03DA02

ATC

medroxyprogesterone; systemic

1.2

7.8

1111

8747

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

31.2

7.8

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

31.2

7.8

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.3

7.8

216

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

7.8

1252

13665

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.1

7.8

WPA15, ,

SPAT

16.0

7.8

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

7.8

188

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

1.8

7.7

114

602

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

3.7

7.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

7.7

4432

38696

G47.3

ICD-10 Finland

Sleep apnoea

0.8

7.7

1207

13204

Z93.3

ICD-10 Finland

Colostomy status

3.2

7.7

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

7.6

8590

78183

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

2.7

7.6

140

SPAT1310

SPAT

Counselling related to known health issue

0.9

7.6

2197

22909

21799

ICD-8 Finland

Benign neoplasm of breast

1.8

7.6

504

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

7.5

992

11033

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

7.5

326

2202

L04AX03

ATC

methotrexate; systemic

0.8

7.5

591

6947

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

42.1

7.5

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

42.1

7.5

JFB00

NOMESCO Finland

Partial resection of small intestine

2.0

7.5

375

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.1

7.4

4714

41361

ZX122

NOMESCO Finland

Intra-arterial

3.9

7.4

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.9

7.4

106

S21

ICPC

Skin texture symptom/complaint

1.2

7.4

1226

9796

A06AD11

ATC

lactulose; oral

1.2

7.4

1117

8850

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

4.4

7.3

JG1CG

NOMESCO Finland

Extensive MRI of rectum

4.4

7.3

PJD99

NOMESCO Finland

Excision of other lymph nodes

17.2

7.3

HA1DG, ,

SPAT

17.2

7.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.3

7.3

570

4199

Z85.4

ICD-10 Finland

Personal history of malignant neoplasm of genital organs

23.4

7.3

E66.8

ICD-10 Finland

Other obesity

0.7

7.3

238

3189

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.8

7.3

786

8917

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

11.1

7.2

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

74.9

7.2

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

74.9

7.2

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

74.9

7.2

WW300

NOMESCO Finland

Transfer of autologic stem cells

74.9

7.2

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

9.4

7.2

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

2.8

7.2

118

A07AA09

ATC

vancomycin; oral

1.8

7.1

102

535

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

1.8

7.1

481

L01XX52

ATC

venetoclax; oral

+∞

7.1

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

7.1

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

+∞

7.1

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

7.1

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

7.1

WB701, ,

NOMESCO Finland

+∞

7.1

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

7.1

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

7.1

197

Kela drug reimbursment

Sunitinib

+∞

7.1

8071/3-C44.9

ICD-O-3

Squamous cell carcinoma, keratinizing, NOS, of skin, NOS

+∞

7.1

8575/3-C50.5

ICD-O-3

Metaplastic carcinoma, NOS, of lower-outer quadrant of breast

+∞

7.1

8480/3-C50.5

ICD-O-3

Mucinous adenocarcinoma of lower-outer quadrant of breast

+∞

7.1

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

7.1

WB201

NOMESCO Finland

Simple neoadjuvant hormone therapy of malignancy

+∞

7.1

8010/3-C50.4

ICD-O-3

Carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.1

WB501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of primary tumour

+∞

7.1

8480/3-C50.3

ICD-O-3

Mucinous adenocarcinoma of lower-inner quadrant of breast

+∞

7.1

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

7.1

8200/3-C50.9

ICD-O-3

Adenoid cystic carcinoma of breast, NOS

+∞

7.1

L01EX05

ATC

regorafenib; oral

+∞

7.1

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.1

399

Kela drug reimbursment

Venetoclax

+∞

7.1

1518, ,

Kela drug reimbursment

+∞

7.1

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

7.1

WB301

NOMESCO Finland

Simple neoadjuvant therapy of malignancy with biomodifiers

+∞

7.1

3009

Kela drug reimbursment

Niraparib

+∞

7.1

8503/3-C50.4

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast

+∞

7.1

18301

ICD-8 Finland

Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary

+∞

7.1

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

7.1

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

7.1

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

+∞

7.1

174

Kela drug reimbursment

Ruxolitinib

+∞

7.1

8507/3-C50.4

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast

+∞

7.1

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

7.1

L01XX35

ATC

anagrelide; oral

+∞

7.1

8010/2-C50.9

ICD-O-3

Carcinoma in situ, NOS, of breast, NOS

+∞

7.1

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

7.1

C574, 8461, 3

ICD-O-3

+∞

7.1

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

+∞

7.1

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

+∞

7.1

L01XE04

ATC

[U] sunitinib

+∞

7.1

C43

ICD-10 Finland

Malignant melanoma of skin

12.5

7.1

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.7

7.1

119

654

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.9

7.0

437

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

7.0

838

9403

HA3RT

NOMESCO Finland

Coagulation of mammary neoplasm under radiological guidance

7.8

7.0

WZC30, ,

SPAT

0.8

7.0

493

5870

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

14.7

6.9

XX9XW, ,

NOMESCO Finland

2.6

6.9

131

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

6.9

100

526

XX9CN, ,

NOMESCO Finland

28.1

6.9

J05AB01

ATC

aciclovir; systemic

1.2

6.9

1973

16452

N06AX11

ATC

mirtazapine; oral

1.1

6.9

3159

27160

NBR30

NOMESCO Finland

Extensive or radical excision of soft tissue tumour of shoulder or upper arm

18.7

6.9

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.9

207

1308

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.9

6.8

2673

27355

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

1.5

6.8

205

1295

N64.4

ICD-10 Finland

Mastodynia

1.4

6.8

314

2145

M05BA04

ATC

alendronic acid; oral

1.2

6.8

970

7639

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

1.8

6.8

516

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

1.9

6.8

402

A10AE04

ATC

insulin glargine; parenteral

0.7

6.8

365

4507

ZZR30

NOMESCO Finland

Flap of muscle

3.4

6.8

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.4

6.7

172

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.2

6.7

219

C10AA07

ATC

rosuvastatin; oral

0.9

6.7

2732

27900

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

9.4

6.7

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.2

6.7

1045

8299

N81.1

ICD-10 Finland

Cystocele

0.8

6.7

622

7172

SDA03

NOMESCO Finland

Periodontal treatment

0.9

6.7

3112

31530

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

6.7

2810

24029

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.8

6.6

465

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

12.9

6.6

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

1.7

6.6

120

674

N60.4

ICD-10 Finland

Mammary duct ectasia

3.3

6.6

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.0

6.6

308

ZXC20

NOMESCO Finland

Use of chemical agents

1.8

6.6

507

KCC30

NOMESCO Finland

Cystectomy with excision of female internal genital organs

37.4

6.5

C54

ICD-10 Finland

Malignant neoplasm of corpus uteri

37.4

6.5

N03AX16

ATC

[U] pregabalin

1.1

6.5

2014

16879

LCD00

NOMESCO Finland

Hysterectomy

1.3

6.5

444

3220

Y16

ICPC

Breast symptom/complaint male

21.1

6.4

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.9

6.4

1939

20194

JMA10

NOMESCO Finland

Transabdominal total splenectomy

3.7

6.4

A10AC01

ATC

insulin (human); parenteral

0.7

6.4

260

3354

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

2.3

6.4

194

N05AX08

ATC

risperidone; systemic

0.8

6.4

440

5257

JAH01

NOMESCO Finland

Laparoscopy

1.4

6.4

310

2137

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

0.8

6.4

637

7284

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.9

6.3

2284

23516

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

3.5

6.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.2

6.3

884

6949

P20

ICPC

Memory disturbance

0.8

6.3

980

10740

N64.1

ICD-10 Finland

Fat necrosis of breast

7.3

6.3

BAA60

NOMESCO Finland

Total thyroidectomy

1.5

6.3

169

1045

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

1.8

6.2

413

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

1.6

6.2

149

896

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

65.6

6.2

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

65.6

6.2

T71

ICPC

Malignant neoplasm thyroid

65.6

6.2

C91.7

ICD-10 Finland

Other lymphoid leukaemia

65.6

6.2

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

65.6

6.2

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

65.6

6.2

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

65.6

6.2

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

65.6

6.2

QC9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in upper extremities, unspecified

8.1

6.2

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

1.7

6.2

110

614

JLC30

NOMESCO Finland

Pancreatoduodenectomy

5.5

6.2

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.4

6.2

221

1445

L88

ICPC

Rheumatoid/seropositive arthritis

0.7

6.2

236

3073

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.6

6.2

143

2045

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

6.1

134

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

6.1

582

6695

L03

ICPC

Low back symptom/complaint

0.9

6.1

2325

23872

TPH00

NOMESCO Finland

Phlebotomy

3.8

6.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.9

6.1

2026

20979

SPAT1262

SPAT

Handing over of treatment supplies

0.8

6.1

889

9800

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

2.6

6.1

118

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

6.1

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

6.1

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

6.1

8201/3-C50.9

ICD-O-3

Cribriform carcinoma, NOS, of breast, NOS

+∞

6.1

L01XK02

ATC

niraparib; oral

+∞

6.1

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

6.1

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

6.1

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

6.1

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

6.1

3019

Kela drug reimbursment

Lenvatinib

+∞

6.1

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

6.1

C84.0

ICD-10 Finland

Mycosis fungoides

+∞

6.1

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

6.1

WD435, ,

NOMESCO Finland

+∞

6.1

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

6.1

8201/3-C50.4

ICD-O-3

Cribriform carcinoma, NOS, of upper-outer quadrant of breast

+∞

6.1

C49.38

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the chest Ewing's sarcoma

+∞

6.1

185

Kela drug reimbursment

docetaxel

+∞

6.1

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

+∞

6.1

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

6.1

EJB40

NOMESCO Finland

Hemiglossectomy

+∞

6.1

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

6.1

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

6.1

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

6.1

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

6.1

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

6.1

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

6.1

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

+∞

6.1

158

Kela drug reimbursment

Everolimus

+∞

6.1

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

6.1

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

6.1

L01EH03

ATC

tucatinib; oral

+∞

6.1

C51.00

ICD-10 Finland

Malignant tumor of the labium majus without histology

+∞

6.1

L01EA01

ATC

imatinib; oral

+∞

6.1

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

6.1

1510

Kela drug reimbursment

Niraparib

+∞

6.1

9699/3-C50.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of breast, NOS

+∞

6.1

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

6.1

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

6.1

302

Kela drug reimbursment

Interferon alfa

+∞

6.1

8480/3-C50.1

ICD-O-3

Mucinous adenocarcinoma of central portion of breast

+∞

6.1

1508

Kela drug reimbursment

Lenvatinib

+∞

6.1

C50.6

ICD-10 Finland

Malignant neoplasm: Axillary tail of breast

+∞

6.1

8503/2-C50.2

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of upper-inner quadrant of breast

+∞

6.1

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

+∞

6.1

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

6.1

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

6.1

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

+∞

6.1

8010/3-C80.9

ICD-O-3

Carcinoma, NOS, of unknown primary site

+∞

6.1

C34.20

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung without histology

+∞

6.1

20199

ICD-8 Finland

Hodgkin's disease

+∞

6.1

C76.1

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Thorax

+∞

6.1

8461/3-C48.2

ICD-O-3

High grade serous carcinoma of peritoneum, NOS

+∞

6.1

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

+∞

6.1

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

+∞

6.1

1BA04, ,

NOMESCO Finland

+∞

6.1

8070/3-C21.1

ICD-O-3

Squamous cell carcinoma, NOS, of anal canal

+∞

6.1

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

6.1

3065, ,

Kela drug reimbursment

+∞

6.1

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

6.1

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

6.1

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

6.1

1512

Kela drug reimbursment

Ibrutinib

+∞

6.1

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

6.1

C49.3

ICD-10 Finland

Malignant neoplasm: Connective and soft tissue of thorax

+∞

6.1

8523/3-C50.8

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of overlapping lesion of breast

+∞

6.1

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

6.1

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

6.1

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

6.1

390

Kela drug reimbursment

Ibrutinib

+∞

6.1

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.1

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

+∞

6.1

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

+∞

6.1

S01AA01

ATC

chloramphenicol; ophthalmic

1.3

6.1

369

2633

SGA01

NOMESCO Finland

Emergency treatment

0.8

6.1

835

9249

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

16.8

6.0

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

10.3

6.0

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

24.9

6.0

HA1WT, ,

NOMESCO Finland

24.9

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768795) Lymph node Pathology biopsy report

446

135

32.26

307.65

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6926

45576

2.30

307.65

11.4

6.7

3.71

4.08

e9/l

41.18

6024

38724

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6881

41826

2.65

307.65

8.3

3.6

10.17

10.44

umol/l

1.15

6647

39035

(4035726) Immunohistochemistry procedure

2783

2358

14.79

307.65

1.5

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1360

167

87.68

307.65

3.2

1.1

32.21

14.50

u/ml

5.98

1312

150

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2063

4583

5.02

307.65

3.5

1.5

13.54

2.75

ug/l

5.24

1575

3410

(40768804) Tissue Pathology biopsy report

5422

31321

2.32

307.65

2.5

1.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

786

101

78.75

307.65

3.2

1.1

36.23

23.14

u/ml

0.95

776

(3002256) Pathology report gross observation

2702

7222

4.40

307.65

1.4

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

289

36.56

307.65

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5914

35666

2.31

307.65

2.7

2.4

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

4451

24097

2.29

307.65

2.4

2.0

—

(40768793) Breast Pathology biopsy report

2316

875

31.70

307.65

1.4

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5178

30919

2.15

300.47

4.9

2.2

2.38

2.37

mmol/l

17.63

4813

27202

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8747

65119

2.77

290.69

10.7

5.8

80.73

76.30

u/l

13.03

8445

60613

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

676

1456

4.58

264.21

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3278

18138

2.02

214.31

2.3

2.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1204

4981

2.43

158.41

3.5

1.5

88.73

23.97

u/ml

1.86

1174

4746

(40758558) Short blood count panel - Blood

3946

25156

1.76

153.14

7.3

4.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1392

6416

2.19

141.18

1.9

2.0

0.22

0.21

g/l

6.26

1331

5857

(3023368) Bacteria identified in Blood by Culture

3110

19377

1.72

124.84

4.2

3.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5457

39711

1.61

116.22

5.8

5.1

1.22

mmol/l

0.65

5061

35984

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6013

44990

1.61

112.31

6.6

5.6

1.22

1.23

mmol/l

0.45

5119

38503

(3003694) ABO and Rh group [Type] in Blood

3092

19804

1.66

108.71

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5193

38301

1.54

96.70

4.5

3.6

35.63

36.17

g/l

10.09

4837

35221

(3033658) Prothrombin time (PT) actual/Normal

2955

19638

1.57

84.79

3.8

3.4

93.68

94.04

0.34

2903

19094

(3042936) Bacteria identified in Isolate by Culture

1715

10125

1.70

78.42

1.9

2.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1256

6778

1.84

78.38

4.5

2.2

252.12

235.42

u/l

3.33

1179

6269

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1990

12446

1.61

71.97

3.0

2.2

0.82

mmol/l

0.25

1864

11395

(3018418) pH of Serum or Plasma

3739

27284

1.44

63.69

4.1

3.3

7.40

0.07

2665

19277

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

448

1798

2.39

61.46

3.0

2.0

2259.49

34.18

u/ml

0.94

394

1447

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.38

60.45

6.4

1.5

28.44

80.60

ug/l

1.25

(4281824) Cell count and differential, peritoneal fluid

205

593

3.28

52.28

1.1

—

(3032080) INR in Blood by Coagulation assay

4760

37440

1.35

46.95

12.9

13.8

1.20

1.23

inr

2.64

3924

30920

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1904

13006

1.45

42.89

1.9

1.8

—

(40768806) Pleura Pathology biopsy report

142

369

3.64

42.77

1.4

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5961

48896

1.34

42.35

4.6

4.1

6.47

6.62

mmol/l

8.18

5702

46053

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1255

7903

1.55

41.90

3.3

3.2

—

(3002030) Lymphocytes/Leukocytes in Blood

4947

39831

1.31

38.30

6.0

27.02

28.95

28.14

4671

37361

(3019069) Monocytes/Leukocytes in Blood

4856

39073

1.31

37.42

6.1

8.94

8.59

10.07

4535

36214

(40758358) Immune stain study

+∞

36.56

1.0

0.0

—

(3006504) Eosinophils/Leukocytes in Blood

4826

39022

1.30

34.85

6.0

2.64

2.91

14.04

4509

36124

(3022096) Basophils/Leukocytes in Blood

4826

39100

1.29

33.97

6.1

0.69

0.71

2.11

4506

36151

(3018010) Neutrophils/Leukocytes in Blood

4835

39211

1.29

33.65

5.9

57.65

56.56

7.68

4598

37070

(3045142) Bone marrow Pathology biopsy report

114

306

3.51

32.81

1.3

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2542

19016

1.33

31.68

3.2

2.3

2.47

2.46

mmol/l

11.29

2300

16780

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1418

9654

1.43

31.54

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

169

588

2.72

31.28

1.3

1.4

32.24

28.99

g/l

2.69

156

510

(3012441) Differential panel - Pleural fluid

134

423

2.99

29.68

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8646

84539

0.72

29.42

5.2

5.5

4.89

4.84

mmol/l

4.01

7889

78809

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8805

85809

0.71

28.94

6.0

6.3

2.81

2.79

mmol/l

1.04

8001

79787

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

218

889

2.32

28.92

1.2

1.3

0.36

0.40

nmol/l

0.42

155

658

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8590

84041

0.72

28.77

5.1

5.4

1.63

1.60

mmol/l

7.96

7790

77873

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1329

9083

1.42

28.74

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

343

1685

1.93

28.02

1.9

2.3

3.62

3.61

g/l

0.02

334

1588

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3463

27376

1.28

27.72

3.5

2.7

31.67

31.26

u/l

0.12

3268

25554

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

755

4688

1.55

26.33

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

970

6353

1.47

26.20

6.4

6.3

1.26

1.32

mmol/l

0.93

953

6220

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

934

6082

1.48

25.96

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8335

81707

0.75

25.54

6.1

6.6

38.65

39.23

mmol/mol

11.19

7635

76099

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

319

1581

1.92

25.41

1.5

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

149

546

2.57

24.97

1.4

2763.13

2683.13

e6/l

0.03

102

378

(3028308) Erythrocytes [#/volume] in Pleural fluid

136

477

2.69

24.88

1.4

38035.62

46747.26

e6/l

0.14

254

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

373

1960

1.81

24.72

1.6

1.9

96.61

96.84

0.07

365

1856

(36304419) Bacteria [Presence] in Urine

2821

22006

1.27

24.43

3.0

3.57

126.44

estimate

0.61

122

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8164

80176

0.76

24.40

4.3

4.5

1.24

1.26

mmol/l

2.74

7286

73404

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

350

1819

1.83

24.05

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

656

4042

1.55

23.64

7.9

8.0

24.54

24.61

mmol/l

0.22

642

3922

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

358

1886

1.80

23.54

1.9

2.3

200.11

183.15

2.72

347

1757

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

238

1104

2.04

22.95

1.3

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

152

586

2.45

22.94

1.8

1.2

—

(3012516) Albumin [Mass/volume] in Urine

2733

30150

0.79

22.67

3.1

3.3

31.82

31.37

mg/l

0.04

1408

16909

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1559

11334

1.34

22.62

1.9

1.8

29.19

0.01

1512

10969

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1736

12840

1.32

22.31

2.8

4.11

4.94

e6/l

1.35

792

5912

(3003396) Base excess in Arterial blood by calculation

1174

8189

1.38

22.18

6.4

0.95

1.34

mmol/l

2.96

1023

6773

(3020682) Albumin/Creatinine [Ratio] in Urine

2781

30558

0.80

22.12

3.7

3.9

6.62

6.54

mg/mmol

0.03

1395

16909

(3009508) Creatinine [Moles/volume] in Urine

2854

31237

0.80

21.84

3.1

3.3

6.11

6.30

mmol/l

2.07

2292

26169

(3019225) pH of Specimen

1245

8792

1.37

21.78

4.2

3.6

7.37

7.36

0.92

884

5624

(3030467) Casts [#/volume] in Urine by Automated count

2935

23265

1.25

21.62

3.1

0.41

0.42

e6/l

0.10

2057

16797

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

311

1616

1.82

21.42

1.6

1.3

—

(3044889) 12 lead EKG panel

6961

60467

1.24

21.34

4.3

4.0

0.44

0.40

—

132

(3019977) pH of Arterial blood

1179

8281

1.37

21.31

6.5

7.42

0.46

578

4710

(3045788) Cell count panel - Pleural fluid

124

451

2.59

21.17

1.5

1.4

—

(3000991) Gas panel - Venous blood

896

6011

1.43

21.16

7.6

7.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

694

4440

1.50

20.95

8.1

8.3

94.62

93.46

6.99

694

4426

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

212

977

2.05

20.84

1.2

56.08

57.19

u/l

0.18

185

841

(3027801) Oxygen [Partial pressure] in Arterial blood

1174

8276

1.37

20.71

6.5

6.4

13.44

11.88

kpa

14.06

1139

7919

(3013115) Eosinophils [#/volume] in Blood

5276

44611

1.22

20.69

6.0

5.9

0.17

0.19

e9/l

20.27

4488

38772

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1174

8278

1.37

20.67

6.5

6.4

5.15

5.09

kpa

1.44

1139

7926

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

225

1064

2.00

20.61

3.4

4.9

593.27

818.78

iu/ml

0.22

139

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

215

1004

2.02

20.40

1.6

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

693

4457

1.49

20.38

8.1

8.2

1.24

1.37

4.33

693

4430

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

393

2220

1.68

20.23

1.5

1.4

207.73

71.22

pmol/l

4.55

383

2167

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

125

467

2.52

20.22

1.1

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

5204

44002

1.22

20.19

5.9

1.73

1.90

e9/l

14.04

4478

38518

(3001604) Monocytes [#/volume] in Blood

5106

43094

1.22

20.18

5.8

0.55

0.56

e9/l

0.64

4272

36831

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

285

1473

1.83

19.99

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

285

1473

1.83

19.99

1.2

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

218

1035

1.99

19.76

3.3

2.1

436.57

21.90

u/ml

1.19

195

929

(3006315) Basophils [#/volume] in Blood

5116

43244

1.21

19.70

5.9

5.8

0.04

e9/l

7.11

4285

36916

(3021589) Normoblasts [#/volume] in Blood

4508

37641

1.21

19.68

12.3

9.9

0.00

e9/l

1.71

3576

30597

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

376

2132

1.67

19.09

2.2

2.9

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

9015

81091

1.33

18.83

19.2

13.2

78.83

77.62

ml/min/173m2

8.12

8555

74425

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

5.32

18.81

1.1

1.3

577.13

27.45

ug/l

0.57

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

984

6850

1.38

18.68

3.7

2.9

1.24

mmol/l

0.36

862

5635

(3007853) Bacteria identified in Skin by Aerobe culture

1292

9382

1.33

18.62

1.7

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

333

1851

1.71

18.23

2.6

3.2

0.37

0.38

iu/ml

0.39

182

1085

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

171

785

2.05

17.07

1.9

2.3

488.33

1000.59

u/ml

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

107

404

2.49

17.01

1.4

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

960

6755

1.36

16.99

7.2

7.1

117.45

119.81

g/l

3.83

947

6591

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

291

2.78

16.99

1.2

10.32

10.75

u/l

0.11

249

(3002582) Erythrocytes [#/volume] in Urine

3293

26982

1.21

16.59

3.2

96.29

69.40

e6/l

0.38

2398

20226

(3004809) Band form neutrophils/Leukocytes in Blood

183

876

1.97

16.29

3.0

2.3

1.63

1.10

1.24

163

762

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1532

11590

1.28

16.09

2.2

2.5

21.21

21.39

0.21

1401

10550

(3014576) Chloride [Moles/volume] in Serum or Plasma

1357

10112

1.29

16.05

6.4

5.8

103.95

103.82

mmol/l

0.40

1357

10107

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

134

577

2.19

15.82

1.1

—

(3016502) Oxygen saturation in Arterial blood

1011

7250

1.34

15.76

6.8

96.05

95.30

3.58

988

6982

(3036489) Thrombin time

435

2680

1.54

15.70

1.5

1.8

20.71

20.96

0.38

399

2305

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

115

469

2.31

15.47

1.5

1.2

5.75

2.55

ug/l

0.35

371

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

161

3.32

15.38

2.4

1.32

0.88

0.84

161

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

104

408

2.40

15.27

5.8

1.2

59.46

309.31

u/ml

3.02

100

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

162

767

1.99

14.92

1.3

1.4

—

(40765096) Chromosome analysis panel by Banding

4.83

14.74

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9162

83017

1.31

14.71

18.6

13.8

22.68

20.91

mg/l

5.96

7720

66741

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1331

10010

1.28

14.56

4.4

4.5

1.04

mmol/l

0.19

1210

9012

(3018095) Leukocytes [#/volume] in Urine

3782

31658

1.19

14.50

3.9

3.8

103.37

122.10

e6/l

0.88

2529

21371

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1876

14699

1.24

14.38

2.8

1.18

1.32

e6/l

0.79

935

7788

(21494814) CD8 cells/Lymphocytes in Specimen

152

3.27

13.99

1.9

2.0

32.23

24.80

2.54

152

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

407

2541

1.52

13.85

1.9

1.8

1.23

2.25

ug/l

2.54

361

2179

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1636

12705

1.24

13.53

2.2

2.4

2.35

2.40

g/l

3.34

1489

11528

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1064

7870

1.29

13.20

2.2

38.68

39.82

u/l

0.09

901

6504

(3013512) EKG study

3803

32030

1.18

13.17

3.7

3.5

0.80

0.71

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

126

571

2.08

13.14

1.3

1.2

21.65

21.70

u/l

0.00

101

477

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

216

1173

1.74

12.98

1.3

38.11

36.66

u/l

0.23

202

898

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

127

581

2.06

12.92

1.3

1.2

65.94

77.90

u/l

1.19

110

502

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1225

9254

1.27

12.83

2.3

2.1

7.33

6.17

umol/l

1.36

1047

7829

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8651

83366

0.81

12.70

5.4

5.5

5.82

5.87

mmol/l

5.69

7807

76565

(1175426) CD3 cells/Lymphocytes in Blood

327

2.41

12.63

1.7

1.9

71.79

73.92

0.57

311

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1184

8948

1.27

12.34

1.5

—

(3051651) Icteric interference index of Serum or Plasma

346

2.34

12.04

2.4

3.7

0.71

0.85

index

1.24

331

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

557

3805

1.39

11.81

8.0

8.2

15.57

15.81

1.47

543

3649

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1118

8443

1.27

11.70

2.7

1.9

394.80

373.71

nmol/l

2.91

1048

7726

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

182

2.84

11.46

1.8

2.5

43.19

47.83

1.13

110

(3022948) Iron [Moles/volume] in Serum or Plasma

1747

13885

1.21

11.38

2.2

2.5

12.40

12.80

umol/l

1.58

1614

12682

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

11.17

1.0

0.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6630

58675

1.16

11.16

5.4

5.1

4760.81

3228.20

e6/l

0.60

733

(3019150) Specific gravity of Urine by Refractometry

2059

22079

0.84

10.85

4.7

1.02

1.16

kg/l

0.81

1379

14404

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

108

503

2.02

10.55

1.1

16.48

17.85

u/l

0.19

430

(3024891) Influenza virus A+B Ag [Presence] in Specimen

301

1872

1.52

10.52

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

108

504

2.01

10.50

1.1

75.67

74.24

u/l

0.10

429

(3023487) Leukocytes [#/volume] in Peritoneal fluid

155

2.90

10.48

1.6

2.3

831.79

1179.67

e6/l

0.20

106

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5220

45516

1.15

10.45

2.5

81.59

2096.54

nmol/l

0.50

4674

40672

(3011412) CD3 cells [#/volume] in Blood

436

2.09

10.43

2.4

2.1

1072.97

1217.90

e6/l

1.12

377

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8613

82797

0.83

10.36

6.4

6.3

1.91

1.92

mu/l

0.23

7906

76934

(3027945) Reticulocytes/Erythrocytes in Blood

1093

8359

1.25

10.22

2.3

2.1

1.81

1.82

0.10

977

7268

(21494434) Karyotype in Bone marrow

330

2.25

10.21

1.2

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

194

1099

1.66

10.08

1.5

1.7

—

(44790048) Parainfluenza type 2 nucleic acid detection

151

798

1.78

10.07

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

151

798

1.78

10.07

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

151

798

1.78

10.07

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

151

798

1.78

10.07

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

9445

86428

1.29

10.07

20.8

16.6

139.63

139.85

mmol/l

13.43

9277

84491

(3044007) Cell count panel - Peritoneal fluid

134

3.01

10.00

1.8

2.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

411

2745

1.42

9.98

2.0

1.8

—

(40768443) Skin Pathology biopsy report

561

3947

1.35

9.92

1.3

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

329

2.23

9.86

2.1

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

329

2.23

9.86

2.1

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

329

2.23

9.86

2.1

1.2

—

(3026782) Osmolality of Urine

1916

15562

1.19

9.70

2.7

2.9

481.37

489.92

mosm/kgh2o

1.04

1643

13417

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

332

2.21

9.66

2.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

439

2992

1.39

9.49

2.3

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

220

2.47

9.33

2.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

220

2.47

9.33

2.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

9448

86565

1.27

9.12

21.1

16.7

3.93

3.95

mmol/l

6.00

9270

84483

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

226

2.41

8.83

2.3

1.2

—

(3014891) Appearance of Pleural fluid

3.64

8.82

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

100

3.19

8.74

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

640

4677

1.30

8.69

1.3

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

110

553

1.87

8.69

1.7

1.5

5.28

6.84

u/l

0.74

436

(3035880) pH of Pleural fluid

224

2.39

8.53

1.2

1.1

7.46

0.03

148

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

6.56

8.52

1.6

1.0

1.26

1.50

ug/l

0.36

(3052851) Hemolysis interference index of Serum or Plasma

335

2234

1.42

8.27

3.0

3.1

3.52

1.37

index

4.98

157

1028

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

241

1509

1.51

8.25

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

206

1272

1.52

7.57

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

874

6739

1.23

7.56

3.4

2.3

64.98

64.96

ml/min/173m2

0.01

386

2779

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

132

734

1.69

7.48

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

108

568

1.79

7.45

3.1

2.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1014

7951

1.21

7.44

3.1

3.2

82.67

81.91

ng/l

0.10

861

6697

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3201

27452

1.13

7.39

3.0

1249.09

1199.46

ng/l

0.30

2740

23364

(3002331) Protein [Mass/volume] in Peritoneal fluid

102

2.94

7.25

1.2

1.6

35.80

21.63

g/l

5.19

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

165

980

1.58

7.22

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

109

587

1.74

6.96

1.8

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2304

19406

1.14

6.96

1.5

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1805

18978

0.87

6.93

1.3

10.17

12.86

u/ml

1.03

642

7379

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

298

3808

0.72

6.91

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2340

19768

1.14

6.73

1.7

1.27

1.06

mg/l

2.29

1856

15332

(3020630) Protein [Mass/volume] in Serum or Plasma

852

6644

1.22

6.62

2.5

1.5

65.50

66.63

g/l

3.84

771

5910

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

7585

68621

1.13

6.59

23.8

16.7

13.79

13.57

36.58

7522

67547

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

204

1297

1.48

6.58

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

119

2.68

6.53

3.2

1.2

65.33

73.72

ng/l

0.11

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7622

73435

0.88

6.51

5.2

5.1

14.93

14.85

pmol/l

2.13

6954

67671

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.69

6.34

1.6

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3252

28113

1.12

6.34

2.8

2.3

252.67

59.44

u/l

0.51

2969

25623

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

102

555

1.73

6.33

1.9

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

102

555

1.73

6.33

1.9

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

102

555

1.73

6.33

1.9

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

112

626

1.68

6.30

3.2

2.2

57.57

58.85

0.25

521

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

190

2.27

6.26

1.2

1.9

933.43

55385.90

u/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

467

1.79

6.26

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

114

642

1.67

6.24

1.8

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

143

853

1.58

6.21

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

139

2.49

6.19

1.8

2.0

4285.73

29102.05

e6/l

0.83

(40768441) Liver Pathology biopsy report

401

1.85

6.19

1.2

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

742

5753

1.22

6.11

6.0

6.2

9.26

9.91

mmol/l

1.74

707

5457

(3005532) Lymphocytes/Leukocytes in Pleural fluid

119

2.60

6.01

1.5

1.3

62.50

59.16

0.20

(3022145) Colonoscopy Study observation

1209

9824

1.17

5.92

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

901

7144

1.20

5.89

4.0

1.34

0.69

7.23

335

1388

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

101

560

1.69

5.89

2.4

2.6

—

(3011544) Albumin [Mass/volume] in Pleural fluid

4.05

5.86

1.3

1.1

16.90

15.82

g/l

0.18

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1953

20216

0.88

5.83

1.3

1.4

34.63

36.97

iu/ml

0.28

605

6530

(3017732) Neutrophils [#/volume] in Blood

1362

11210

1.16

5.64

3.6

2.7

3.91

4.35

e9/l

4.46

1164

9495

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

10.40

5.54

1.2

1.0

—

(3042631) Mycobacterium sp identified in Specimen

135

818

1.55

5.53

3.0

—

(21494755) Public health laboratory ask at order entry panel

526

6045

0.80

5.52

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

809

6400

1.20

5.43

2.3

2.1

69.90

70.53

e9/l

0.18

579

4733

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

116

1678

0.64

5.33

2.2

2.3

122.83

65.92

ug/min

0.68

896

(3001893) Eosinophils/Leukocytes in Pleural fluid

2.65

5.33

1.5

1.2

1.59

3.02

0.55

(3018834) Bilirubin.total [Presence] in Urine by Test strip

6.08

5.25

3.2

1.2

—

estimate

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.29

5.24

1.1

0.46

0.49

nmol/l

0.05

(3022475) Manganese [Moles/volume] in Blood

3.54

5.21

1.1

0.17

0.16

umol/l

0.26

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

346

2509

1.30

5.12

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

5.08

1.0

0.0

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

7163

68975

0.90

5.06

25.2

18.3

329.82

330.37

g/l

6.92

7121

68609

(40767503) Oxygen content in Capillary blood by calculation

216

1463

1.39

5.04

2.5

16.09

16.36

0.69

208

1434

(3009343) pH of Capillary blood

593

4593

1.22

4.98

3.3

7.42

0.72

489

3793

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.57

4.97

1.9

3.6

0.70

1.97

mg/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

148

940

1.48

4.91

1.2

21.86

18.15

u/l

1.55

134

752

(40761536) Microorganisms panel - Urine sediment

812

6490

1.18

4.87

4.4

4.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4008

39614

0.91

4.86

2.0

1.9

1.28

1.32

mmol/l

4.01

3216

32844

(1761868) Lipid panel - Serum or Plasma

3163

31582

0.91

4.73

3.2

3.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

365

2699

1.27

4.67

1.4

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

531

4096

1.22

4.67

1.4

1.3

44.20

35.18

iu/l

6.08

441

3629

(3002179) Metamyelocytes/Leukocytes in Blood

851

6856

1.18

4.65

3.8

1.11

0.53

5.43

306

1365

(3017143) Hepatitis C virus Ab [Presence] in Serum

897

7259

1.17

4.64

1.4

1.5

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.25

4.61

1.5

1.3

20.67

12.83

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

109

1545

0.66

4.61

1.3

1.8

0.82

0.81

nmol/l

0.06

1282

(3035933) Granulocytes/Leukocytes in Blood

225

1560

1.36

4.59

2.7

3.0

58.46

57.66

0.39

225

1560

(3051611) Lipemic interference index of Serum or Plasma

129

809

1.50

4.58

2.7

3.3

13.85

13.51

index

0.13

331

(4034850) Laboratory test

249

3059

0.76

4.56

13.0

9.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

6680

60470

1.10

4.48

5.1

5.0

2.01

136.72

—

(3028271) Lactate [Moles/volume] in Capillary blood

167

1108

1.42

4.44

1.7

1.8

1.71

1.66

mmol/l

0.26

158

1083

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3685

36448

0.91

4.40

4.4

2.71

0.80

estimate

0.88

801

7447

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2614

22698

1.10

4.39

2.3

2.4

2.87

2.82

mg/l

0.43

2204

19595

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

602

4743

1.20

4.28

3.3

5.22

5.24

kpa

0.17

574

4472

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

260

1864

1.31

4.25

2.3

2.6

1.44

1.59

mg/l

2.75

235

1639

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

514

3993

1.21

4.24

3.2

2.22

2.13

mmol/l

0.22

397

3043

(3037692) Legionella sp identified in Specimen by Organism specific culture

195

1.97

4.02

1.1

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

451

1.62

4.01

1.8

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1982

17044

1.11

3.99

3.9

148.72

285.41

ng/l

3.30

1557

12925

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

546

4295

1.20

3.97

3.5

3.4

24.30

24.58

mmol/l

1.11

535

4234

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1991

20180

0.90

3.92

1.7

71644129.38

36105543.15

pmol/l

1.10

1594

16596

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

348

1.70

3.86

1.3

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

3.86

0.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

371

1.67

3.80

1.3

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.76

3.77

1.4

1.2

—

(3012501) Base excess in Blood by calculation

203

1433

1.33

3.75

3.1

3.4

2.64

2.73

mmol/l

0.17

159

1010

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

804

6566

1.16

3.74

3.2

3.1

4.40

4.43

pmol/l

0.40

733

5775

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1141

0.64

3.73

1.1

97.04

12195.57

iu/ml

0.57

202

(3026692) Albumin [Mass/volume] in Peritoneal fluid

126

2.16

3.63

1.1

1.4

17.60

10.95

g/l

3.25

(40761535) Cells panel - Urine sediment

648

7013

0.85

3.63

3.6

—

2.17

—

(3012544) pH of Venous blood

949

7861

1.14

3.61

3.2

3.4

7.38

0.12

507

4389

(3021440) Promyelocytes/Leukocytes in Blood

848

6971

1.15

3.61

4.1

4.0

0.24

0.05

4.96

286

1217

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

165

1139

1.36

3.55

1.5

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

586

1.50

3.53

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

166

1149

1.36

3.52

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2248

22538

0.91

3.48

1.3

1.66

1.49

u/ml

0.19

512

6107

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

168

1168

1.35

3.47

2.0

25.35

25.21

mg/l

0.01

387

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

297

3438

0.80

3.45

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

567

1.51

3.44

1.1

—

(3000494) Fungus identified in Specimen by Culture

1248

10549

1.12

3.44

1.5

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

148

2.03

3.44

2.0

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

142

2.04

3.42

2.0

1.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

155

1068

1.36

3.40

1.5

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

419

3269

1.21

3.38

1.6

1.65

g/l

0.01

353

2796

(3008898) HLA-B27 [Presence]

266

3105

0.80

3.34

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

164

1144

1.35

3.33

1.5

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6032

54683

1.08

3.32

3.3

3.1

46.71

39.93

u/l

5.73

5542

50783

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

329

1.65

3.28

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

389

4351

0.83

3.24

1.5

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.38

3.23

2.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

255

1899

1.26

3.20

2.4

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

2138

18658

1.09

3.11

2.7

2.6

7.87

7.52

e6/l

0.41

1924

16853

(44786800) Granulocytes/Leukocytes in Body fluid

2.97

3.10

1.2

1.3

29.05

25.22

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

122

822

1.39

3.10

5.1

6.3

12.13

12.70

mg/l

0.78

111

751

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

166

1175

1.33

3.08

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

153

1073

1.34

3.03

1.6

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

223

1647

1.27

3.02

1.5

1.7

—

(3002032) Base excess in Venous blood by calculation

905

7572

1.13

2.98

3.3

3.4

1.74

2.11

mmol/l

2.30

813

6783

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

353

1.59

2.97

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

353

1.59

2.97

1.4

1.3

—

(3035715) Granulocytes [#/volume] in Blood

184

1330

1.30

2.96

2.8

3.1

4.34

3.96

e9/l

1.07

184

1330

(3005988) Vibrio sp identified in Specimen by Organism specific culture

153

1078

1.33

2.95

1.6

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2114

18481

1.09

2.95

4.4

4.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

259

1955

1.25

2.93

2.1

125.08

127.80

g/l

0.94

186

1488

(3008295) Osmolality of Serum or Plasma

138

959

1.35

2.92

1.5

1.4

275.84

273.82

mosm/kgh2o

0.49

103

704

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

328

2540

1.21

2.91

3.6

3.4

25.22

25.21

mmol/l

0.02

301

2278

(3005719) IgG [Mass/volume] in Serum or Plasma

739

6121

1.14

2.86

3.0

2.6

10.05

10.50

g/l

2.22

679

5619

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

4.01

2.80

1.0

352.00

180.14

u/l

—

(3029937) Albumin [Presence] in Urine by Test strip

2735

26992

0.93

2.80

4.5

4.6

0.01

0.00

estimate

0.66

957

8965

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

160

1145

1.31

2.79

1.3

28.79

28.62

u/ml

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

248

2852

0.81

2.78

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.32

2.77

1.5

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.83

2.69

1.0

—

(3025159) Blasts/Leukocytes in Blood

843

7072

1.12

2.68

4.1

4.2

0.66

0.03

0.98

262

1176

(3028626) Oxygen [Partial pressure] in Capillary blood

215

1609

1.25

2.66

2.7

2.8

8.16

8.11

kpa

0.16

206

1570

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

145

1032

1.32

2.65

1.3

1.4

141.20

162.41

au/ml

1.20

311

(3021447) Carbon dioxide [Partial pressure] in Venous blood

924

7806

1.12

2.61

3.3

3.4

5.78

5.86

kpa

1.66

900

7615

(3021901) Oxygen saturation in Capillary blood

192

1423

1.27

2.58

2.8

2.9

89.96

90.20

0.19

183

1383

(3008536) Aspergillus sp Ab [Presence] in Serum

2.15

2.57

3.0

1.3

—

(3022689) Creatine [Moles/volume] in Urine

309

0.45

2.53

1.3

1.5

7.61

6.86

mmol/l

0.36

309

(3015171) Extractable nuclear Ab [Units/volume] in Serum

401

4366

0.85

2.51

1.3

2.05

0.77

u/ml

0.57

370

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

392

1.51

2.50

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

342

1.53

2.43

2.9

2.1

232.98

219.51

e6/l

0.19

288

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

706

0.65

2.43

1.2

208.57

215.13

titre

—

115

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

328

1.54

2.40

1.6

1.5

32.11

30.85

umol/l

0.41

307

(3013139) Helicobacter pylori Ag [Presence] in Stool

723

7530

0.89

2.38

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

199

1499

1.25

2.36

1.4

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.12

2.36

1.2

0.45

1.65

mmol/l

0.88

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

135

1631

0.77

2.36

1.1

0.98

1.28

u/ml

0.33

835

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

491

5238

0.87

2.36

1.9

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

330

1.53

2.34

1.6

1.5

2.03

2.00

umol/l

0.07

298

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

527

0.60

2.32

1.3

1.5

79.37

57.36

ug/l

1.54

527

(3014051) Protein [Presence] in Urine by Test strip

2895

25824

1.07

2.30

3.3

3.2

0.16

0.07

0.51

780

(40761539) Cells [Type] in Urine sediment by Light microscopy

158

1.78

2.29

1.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

158

1163

1.27

2.29

1.1

—

(40758292) HTLV I+II Ab panel - Serum

2.30

2.27

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

128

1547

0.77

2.26

1.4

1.5

1111.71

1041.64

mu/l

0.34

1219

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1041

0.73

2.20

1.2

1.3

7.17

7.48

mmol/l

0.42

894

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

256

2858

0.83

2.20

1.4

1.5

7.43

8.05

iu/ml

0.02

534

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

203

1.66

2.19

1.2

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

598

6262

0.89

2.18

1.3

149.17

174.24

u/ml

0.56

553

5821

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

159

1180

1.26

2.18

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1324

11506

1.09

2.13

5.2

5.4

33.94

33.57

0.59

800

7465

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

338

1.50

2.13

2.8

2.1

498.30

443.92

e6/l

0.47

269

(3016879) Cocaine [Presence] in Urine

126

1508

0.78

2.09

2.1

1.5

—

(3003181) Sodium [Moles/volume] in Urine

249

1949

1.20

2.08

1.5

1.4

64.99

60.03

mmol/l

0.97

201

1557

(3028026) IgM [Mass/volume] in Serum or Plasma

572

4770

1.13

2.07

2.0

1.6

1.35

1.28

g/l

0.33

523

4357

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

779

0.69

2.06

1.3

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

461

0.61

2.02

1.5

1.23

1.29

nmol/l

0.10

349

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.01

2.02

3.0

1.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

735

7570

0.90

2.01

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

335

1.48

2.01

1.3

64.81

72.73

nmol/24h

0.54

335

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

530

1.38

2.01

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

110

1.87

2.00

1.2

1.88

1.70

mmol/l

0.19

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.22

1.97

1.6

1.9

—

(3025130) Human papilloma virus identified in Specimen

220

1712

1.21

1.97

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

683

7052

0.90

1.97

2.2

2.4

4.96

5.82

ug/l

0.93

558

6017

(1002224) Polysomnography panel

335

3617

0.86

1.96

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

442

4677

0.88

1.94

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

202

1563

1.21

1.93

1.6

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

657

0.68

1.92

1.5

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

536

1.36

1.89

1.3

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

113

1.82

1.86

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

321

0.55

1.85

9.5

11.6

798.00

4846.63

nmol/l

0.50

309

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

403

0.60

1.84

1.0

1.1

1956.44

1534.17

miu/ml

0.89

403

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

539

1.36

1.84

2.1

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.12

1.82

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.02

1.82

1.4

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

713

1.30

1.78

3.7

3.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

416

4379

0.88

1.71

1.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.67

1.71

1.1

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

103

1.82

1.70

1.7

2.3

4.20

5.28

ug/l

0.73

103

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

367

3889

0.88

1.68

1.6

15.43

18.55

u/ml

0.37

799

(3028707) Methadone [Presence] in Urine by Screen method

747

0.72

1.68

3.2

1.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

9596

90268

0.90

1.68

29.7

21.4

129.77

132.58

g/l

94.50

9498

89096

(44813793) Dust mix specific IgE antibody measurement

736

0.72

1.68

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.87

1.67

1.0

—

(3010813) Leukocytes [#/volume] in Blood

9596

90266

0.90

1.67

29.5

21.3

6.38

6.53

e9/l

7.71

9394

87654

(3015235) Bicarbonate [Moles/volume] in Capillary blood

306

2492

1.15

1.65

2.5

2.7

25.58

25.37

mmol/l

0.43

296

2450

(3047189) Immunofixation for 24 hour Urine

205

1.55

1.65

1.4

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9482

88052

1.10

1.64

15.6

10.8

24.24

23.38

u/l

2.19

9250

84866

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.85

1.62

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.85

1.62

1.0

—

(3026361) Erythrocytes [#/volume] in Blood

9596

90258

0.91

1.62

29.5

21.3

4.32

4.41

e12/l

74.91

9390

87654

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

9596

90257

0.91

1.62

29.9

21.6

39.50

40.13

0.82

9495

89036

(43055514) Macroprolactin [Presence] in Serum or Plasma

119

1.73

1.61

1.4

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

143

1628

0.82

1.60

1.2

1.3

68.00

84.14

titre

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

9596

90250

0.91

1.58

29.4

21.2

91.70

91.19

26.55

9495

89063

(3035941) MCH [Entitic mass]

9596

90249

0.91

1.58

29.4

21.2

30.30

30.19

9.28

9494

89062

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

334

2747

1.14

1.58

1.8

2.1

322.21

573.43

ug/l

1.75

300

2577

(3028300) Cannabinoids [Presence] in Urine

145

1643

0.82

1.55

2.0

1.5

—

(3024928) Oxygen saturation in Venous blood

238

1913

1.17

1.54

2.1

2.8

60.83

60.44

0.10

229

1849

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

735

0.74

1.54

1.0

915.76

366.63

ng/l

0.48

513

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

113

846

1.25

1.53

1.9

1.6

32.65

31.80

1.22

113

838

(1616796) Gas panel - Central venous blood

189

1492

1.19

1.53

3.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

743

0.74

1.51

1.0

47.68

47.44

ng/l

0.01

511

(3000764) Benzodiazepines [Presence] in Urine

144

1627

0.83

1.51

2.0

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

192

0.49

1.50

1.4

1.6

—

(3007461) Platelets [#/volume] in Blood

9596

90233

0.91

1.50

29.5

21.3

259.19

261.69

e9/l

3.38

9407

88040

(46235355) HIV 1 and 2 tests - Meaningful Use set

1125

9863

1.07

1.50

1.6

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

117

0.40

1.50

1.0

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

288

0.58

1.49

1.6

1.9

8.61

9.42

mg/l

0.18

243

(1001926) Buprenorphine [Presence] in Urine by Screen method

110

1276

0.80

1.49

2.2

1.5

—

(3027008) Opiates [Presence] in Urine

145

1635

0.83

1.49

2.0

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

382

1.37

1.49

1.1

73.17

83.41

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

834

0.76

1.46

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

152

1.60

1.46

1.6

1.5

72.45

71.77

0.09

147

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3709

33676

1.05

1.45

3.9

3.7

30.42

59.17

ng/l

2.14

2643

22550

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.99

1.45

1.0

2.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

544

4630

1.10

1.45

5.8

6.1

25.11

24.82

mmol/l

1.16

526

4437

(3003888) Timothy IgE Ab [Units/volume] in Serum

120

1373

0.82

1.44

1.1

4.96

2.81

u/ml

0.54

640

(3006270) Folate [Moles/volume] in Blood

101

753

1.26

1.44

1.2

326.62

367.13

nmol/l

1.21

632

(3006245) CD3-CD19+ cells/cells in Blood

175

1.55

1.43

1.4

2.0

14.50

8.18

1.07

164

(3027944) Amphetamines [Presence] in Urine

144

1616

0.83

1.42

2.0

1.5

—

(3000012) Reticulocyte production index

119

906

1.23

1.41

1.9

1.7

0.82

0.88

0.69

542

(3023420) DNA double strand Ab [Units/volume] in Serum

430

4454

0.90

1.39

1.5

1.8

6.13

7.44

iu/ml

0.45

1068

(3004775) Volume in Urine collected for unspecified duration

549

0.71

1.38

2.0

2.4

598.56

626.11

0.18

398

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9569

88961

1.09

1.38

25.3

18.1

69.89

70.56

umol/l

1.95

9465

87682

(3007916) DNA double strand Ab [Titer] in Serum

151

0.50

1.36

1.1

1.4

—

217.45

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

117

1332

0.82

1.36

1.1

0.92

0.76

u/ml

0.16

525

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

739

0.76

1.35

1.0

743.22

734.53

ng/l

0.05

492

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1111

11028

0.93

1.34

7.2

6.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.55

1.32

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

693

0.75

1.31

1.9

1.7

415.46

381.74

mu/l

0.26

544

(3009466) Valproate [Moles/volume] in Serum or Plasma

100

1152

0.81

1.31

4.4

5.2

372.54

367.56

umol/l

0.13

1000

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1036

0.80

1.29

1.0

1.1

2.50

3.14

u/ml

0.21

416

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

146

1618

0.84

1.28

1.2

1.3

132.31

300.52

titre

2.70

162

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.34

1.28

1.1

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

192

2079

0.86

1.27

1.2

1.1

0.58

0.60

ratio

0.14

318

(3034092) Cytoplasmic Ig cells/cells in Blood

108

0.43

1.25

13.8

9.1

0.16

0.21

—

108

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

111

0.42

1.24

1.2

1.1

1.95

1.58

umol/24h

—

111

(3048689) Calprotectin [Mass/mass] in Stool

1266

12479

0.94

1.24

2.1

132.18

119.29

ug/g

0.28

986

9691

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

127

990

1.20

1.23

1.2

30.15

20.74

u/l

1.05

108

859

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

439

0.70

1.23

1.1

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

444

4554

0.91

1.22

1.1

515.50

178.34

titre

1.25

109

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

183

1477

1.16

1.19

1.3

1.2

0.14

0.23

nmol/l

1.52

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.14

1.19

1.1

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

104

798

1.22

1.19

1.3

1.2

111.84

110.73

pmol/l

0.08

104

798

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1096

0.82

1.18

1.0

1.1

4.35

2.84

u/ml

0.52

501

(3021960) Folate [Moles/volume] in Serum or Plasma

2991

27138

1.04

1.18

1.7

21.39

21.51

nmol/l

0.16

2448

22521

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

510

4381

1.09

1.18

1.3

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

391

0.69

1.18

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

768

6711

1.08

1.17

2.8

2.9

4.48

4.42

kpa

0.41

749

6542

(3040151) Glucose [Moles/volume] in Capillary blood

109

843

1.21

1.16

5.5

8.5

6.88

7.52

mmol/l

1.01

691

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

343

1.34

1.16

1.2

10.78

11.23

mm/h

0.10

343

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.08

1.16

1.1

—

(3019060) Gas panel - Arterial blood

515

4429

1.09

1.16

3.8

4.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1042

0.81

1.16

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

156

1248

1.17

1.15

1.3

1.2

0.19

0.18

nmol/l

0.10

122

964

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

289

0.65

1.15

2.0

1.7

9.97

9.02

ug/l

0.42

289

(44816559) Phosphatidylethanol [Mass/volume] in Blood

249

2624

0.88

1.14

1.3

1.5

0.32

0.30

mg/l

0.22

111

1044

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

492

1.28

1.14

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

337

3489

0.90

1.13

1.3

48.39

48.68

u/ml

0.00

203

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

283

2958

0.89

1.13

1.4

1.8

0.23

g/l

0.03

269

2806

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

141

1121

1.18

1.13

1.1

1.2

276.42

285.94

u/ml

0.15

704

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.66

1.12

1.1

1.2

22.70

76.60

ng/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.66

1.12

1.1

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

311

3230

0.90

1.12

1.3

2.66

6.31

u/ml

1.03

322

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

248

2609

0.89

1.11

1.2

1.3

41.03

51.67

u/ml

0.46

264

(3023183) Ammonium ion [Moles/volume] in Plasma

163

1313

1.16

1.11

2.7

2.5

36.36

31.72

umol/l

1.55

140

1170

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.84

1.11

3.3

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

1440

14091

0.95

1.11

1.3

1.4

478.14

582.24

titre

1.75

345

3392

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

308

0.67

1.10

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

108

1208

0.83

1.10

1.1

0.79

1.02

u/ml

0.25

570

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

214

2269

0.88

1.09

1.2

1.66

1.62

g/l

1.43

214

2269

(3020876) Protein [Mass/time] in 24 hour Urine

756

1.21

1.09

2.1

1.9

0.55

1.00

g/24h

2.72

375

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

235

1.39

1.08

2.7

2.0

165.91

160.72

0.13

217

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

123

1358

0.85

1.08

1.6

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

154

0.55

1.08

3.1

2.0

13.54

17.80

umol/l

—

154

(3024980) IgG subclass 4 [Mass/volume] in Serum

133

1458

0.85

1.08

1.4

1.5

0.59

0.67

g/l

0.66

106

1134

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

150

1.50

1.07

1.7

1.5

385.92

518.86

mu/l

0.93

145

(3001729) Color of Synovial fluid

1.76

1.06

2.5

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

147

1181

1.17

1.05

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

366

1.30

1.05

1.8

1.6

0.40

0.36

ug/l

0.28

247

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

113

1.57

1.04

1.1

1.6

1300006.13

323339.38

nmol/l

0.50

(3044242) Glucose [Moles/volume] in Arterial blood

383

1.30

1.04

2.0

2.1

8.52

8.28

mmol/l

0.09

383

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

100

778

1.20

1.04

2.0

2.2

2.14

5.60

u/field

0.54

404

(4212803) Bone marrow aspirate examination

1.96

1.03

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

291

3016

0.90

1.03

1.4

1.7

1.18

1.21

g/l

1.23

279

2862

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

476

0.75

1.02

1.1

1.04

1.06

ratio

1.03

386

(3003329) Lymphocytes/Leukocytes in Synovial fluid

880

0.82

1.00

1.9

1.5

37.57

33.12

0.45

500

(3007930) Methemoglobin/Hemoglobin.total in Blood

378

3233

1.10

1.00

4.0

4.3

0.88

0.09

363

3061

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

313

3224

0.90

0.99

1.3

9.59

6.91

u/ml

0.31

517

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

100

1.59

0.98

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

547

4758

1.08

0.98

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

411

4174

0.92

0.97

1.3

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.97

0.0

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

209

1736

1.13

0.96

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

146

1184

1.16

0.95

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.24

0.94

9.3

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

289

2449

1.11

0.94

2.0

1.4

0.03

0.00

g/l

0.95

252

2201

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

753

7464

0.94

0.93

1.6

1.35

1.39

0.90

645

6491

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.77

0.93

1.3

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

227

1.36

0.92

2.6

3.2

10.84

10.47

kpa

0.26

227

(3033923) Metanephrine [Moles/time] in 24 hour Urine

240

0.66

0.92

1.2

1.1

0.69

0.65

umol/24h

—

109

(3039162) Centromere protein B Ab [Units/volume] in Serum

135

1454

0.87

0.91

1.3

90.01

63.44

u/ml

0.42

105

(3001964) Herpes simplex virus Ag [Presence] in Specimen

188

1.39

0.90

1.1

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

909

0.83

0.90

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

196

1.38

0.90

2.1

2.5

0.61

mmol/l

0.05

196

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.48

0.89

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

104

1139

0.85

0.88

1.7

2.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.56

0.87

1.1

1.3

—

(3044927) Protein electrophoresis panel - Urine

874

0.83

0.86

1.1

1.2

—

(4198724) Urine methamphetamine measurement

180

0.62

0.86

1.0

1.3

—

(3036603) Volume of Urine

582

1.21

0.84

1.4

1748.53

1904.95

0.92

561

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

412

3571

1.08

0.84

3.8

4.1

1.56

1.57

0.10

395

3392

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

1.94

0.84

1.2

4.0

48.50

381.31

umol/l

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.94

0.84

3.7

3.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

244

2069

1.11

0.81

1.7

1.9

5.44

5.03

mmol/24h

1.05

207

1825

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

222

0.67

0.81

1.1

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

619

1.19

0.81

1.6

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

654

1.19

0.80

1.1

1.3

2.44

2.15

mmol/l

0.66

604

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

161

1.39

0.79

1.1

—

(3000330) Specific gravity of Urine by Test strip

550

4832

1.07

0.79

3.2

3.6

1.02

ratio

0.69

491

4343

(3001556) Androgen free Index in Serum or Plasma

0.00

0.78

0.0

1.1

—

(3022621) pH of Urine by Test strip

807

7927

0.95

0.77

3.2

2.9

6.15

6.09

1.01

531

5315

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

520

1.21

0.77

1.1

20.33

17.21

u/ml

0.20

197

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

913

0.85

0.77

1.4

1.5

65.16

59.96

ug/l

0.39

726

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.77

0.0

2.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

341

2948

1.08

0.76

2.2

1.5

0.56

0.33

g/l

0.96

280

2481

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

227

1.32

0.76

2.6

3.2

5.11

5.19

kpa

0.16

227

(3004451) EKG impression Narrative

461

1.22

0.76

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

244

2078

1.10

0.76

3.5

3.6

0.84

0.82

nmol/l

0.18

197

1725

(40762365) Oxygen content in Arterial blood by calculation

1.58

0.76

1.4

2.1

14.03

15.12

ml/dl

0.93

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

771

1.17

0.76

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

159

1665

0.89

0.74

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

798

0.84

0.74

1.5

—

3.17

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.82

0.73

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

143

1504

0.89

0.72

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

474

1.20

0.71

1.4

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

3267

1.08

0.71

2.0

1.4

2.96

2.91

g/l

0.38

331

2870

(3020191) Ethanol [Moles/volume] in Serum or Plasma

499

0.80

0.71

1.2

1.5

1.10

1.06

promille

0.08

373

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

222

1.31

0.71

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

253

2169

1.09

0.70

3.7

4.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.56

0.70

1.3

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

249

2536

0.92

0.69

1.7

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

278

0.74

0.69

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

278

0.74

0.69

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

278

0.74

0.69

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

278

0.74

0.69

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

553

1.18

0.69

1.5

1.3

34.77

23.25

umol/l

1.75

502

(3017446) Testosterone [Moles/volume] in Serum or Plasma

399

1.22

0.69

1.3

1.4

0.94

1.37

nmol/l

1.87

326

(3017704) Immunofixation for Urine

393

0.78

0.68

1.5

1.2

—

(36660697) Celiac disease serology panel - Serum

890

7972

1.05

0.68

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.48

0.68

1.1

1.0

0.02

0.05

u/ml

0.86

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

929

0.86

0.66

1.0

0.40

0.25

u/ml

0.21

282

(3016750) Collection duration of Urine

400

0.79

0.64

1.9

2.3

496.95

503.15

min

0.14

318

(37208534) Antinuclear antibody arbitrary concentration in serum

326

1.23

0.64

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

152

1.35

0.64

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

112

1.42

0.64

1.1

1.0

8.69

8.48

u/ml

0.02

112

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

103

846

1.14

0.63

1.1

97.66

95.14

0.43

788

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

664

0.84

0.63

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

541

1.18

0.63

2.3

2.4

18.59

25.60

iu/ml

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

220

0.72

0.63

1.4

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

396

1.21

0.62

1.8

106.17

102.31

0.27

361

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.60

0.0

6.0

—

334.84

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.15

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.06

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

154

1.34

0.60

1.2

1.1

—

(3003129) Base excess in Capillary blood by calculation

105

869

1.13

0.59

2.1

1.58

1.17

mmol/l

0.56

843

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

739

0.86

0.59

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

711

1.15

0.59

1.5

1.3

41.25

62.45

titre

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

392

3450

1.06

0.59

2.0

1.4

3.64

g/l

0.01

348

3060

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

152

0.68

0.59

1.5

1.7

1.24

1.19

mmol/l

1.26

147

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

271

2355

1.08

0.58

2.0

1.4

0.00

g/l

0.15

234

2055

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

1.4

—

111.18

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

272

2733

0.93

0.58

1.3

1.42

6.06

u/ml

1.91

180

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.47

0.58

1.6

1.9

1.40

1.34

umol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

657

0.85

0.58

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

392

3454

1.06

0.57

2.0

1.4

4.23

4.29

g/l

0.88

348

3062

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.70

0.57

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

696

1.14

0.57

2.4

2.8

30.34

26.12

mg/l

0.40

488

(3037121) Protein [Mass/volume] in Urine

297

2594

1.07

0.57

3.0

2.6

426.70

601.22

mg/l

0.23

103

722

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.47

0.56

1.0

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

132

1112

1.11

0.56

1.1

123.51

123.89

0.04

117

990

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.65

0.56

1.2

1.1

0.03

u/ml

—

(3047181) Lactate [Moles/volume] in Blood

257

2234

1.08

0.56

4.1

4.8

1.17

1.29

mmol/l

1.35

235

1971

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.55

1.4

1.1

5.62

6.11

mmol/l

—

(4024509) Urine culture

524

5147

0.95

0.55

2.1

2.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

724

1.14

0.55

1.4

1.3

128.33

677.36

titre

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

268

2335

1.08

0.55

2.9

1.5

1.58

1.44

ratio

0.34

140

1373

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

151

1283

1.10

0.55

1.3

453.76

310.67

pmol/l

0.38

131

1120

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

392

3462

1.06

0.54

2.0

1.4

7.55

7.61

g/l

0.26

348

3067

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3080

29291

0.98

0.54

2.1

143.94

174.42

u/l

2.61

2903

27425

(3043409) Potassium [Moles/volume] in Arterial blood

236

2049

1.08

0.54

3.8

4.1

3.81

mmol/l

0.07

236

2036

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.56

0.53

1.0

0.08

0.39

u/ml

—

(3010937) Rubella virus Ab [Presence] in Serum

1.56

0.53

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.49

0.53

1.1

1.81

1.57

iu/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

253

2207

1.07

0.52

2.1

1.5

0.00

g/l

-0.00

232

2048

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

388

1.18

0.51

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

285

1.21

0.51

2.8

2.0

50.82

52.12

umol/l

0.10

232

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

110

924

1.11

0.51

1.6

1.5

—

(3034891) Synovial lining cells/cells in Synovial fluid

498

0.84

0.51

1.5

3.08

4.57

0.35

(3004119) Hemoglobin [Mass/volume] in Venous blood

562

5025

1.05

0.51

2.6

3.0

124.76

128.38

g/l

3.99

547

4881

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

220

2213

0.93

0.51

1.3

228.40

223.04

miu/ml

0.07

1057

(3004616) Nuclear Ab [Presence] in Serum

136

1396

0.91

0.50

1.4

1.3

—

(4062490) Immunoglobulin typing, IgG

894

0.89

0.49

1.2

1.4

—

(40768446) Kidney Pathology biopsy report

230

0.77

0.48

1.6

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

219

1.24

0.48

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

443

1.16

0.48

1.4

1.7

3.88

3.85

nmol/l

0.01

357

(40768797) Stomach Pathology biopsy report

1472

13424

1.03

0.48

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

322

0.81

0.47

1.2

0.30

0.31

g/l

0.54

266

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

316

3130

0.94

0.47

1.2

1.3

—

(3042733) HLA Ab [Presence] in Serum

166

0.73

0.47

4.5

4.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

842

0.89

0.47

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

822

0.89

0.47

1.0

1.1

—

72.11

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

685

6167

1.04

0.47

1.3

68.00

52.65

au/ml

1.03

383

(3025018) Bordetella pertussis Ab [Titer] in Serum

653

0.87

0.47

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

493

0.85

0.46

1.0

0.35

1.33

u/ml

0.93

152

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

462

1.15

0.46

2.6

1816.14

790.29

u/ml

0.50

453

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

303

2675

1.06

0.45

3.0

1.5

34.77

30.77

mg/l

0.41

257

2251

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

849

0.89

0.45

1.4

0.98

0.96

ratio

0.10

501

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

849

0.89

0.45

1.4

1.25

1.16

ratio

0.33

501

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

849

0.89

0.45

1.4

1.28

1.19

ratio

0.38

504

(3036670) Protein [Mass/volume] in Synovial fluid

281

1.20

0.45

1.3

39.68

38.70

g/l

0.18

145

(3006653) Thiamine [Moles/volume] in Blood

411

1.16

0.45

1.3

142.27

132.47

nmol/l

0.60

411

(3027135) IgG subclass 1 [Mass/volume] in Serum

917

0.90

0.45

1.2

1.4

6.54

6.62

g/l

0.07

672

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

749

0.89

0.44

1.4

1.75

1.42

nmol/l

1.14

672

(3012494) Peanut IgE Ab [Units/volume] in Serum

237

0.79

0.44

1.0

0.28

0.96

u/ml

—

118

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

430

0.85

0.44

1.0

1.1

1.30

1.13

u/l

0.43

183

(3024139) IgG subclass 3 [Mass/volume] in Serum

915

0.90

0.44

1.2

1.4

0.45

0.39

g/l

0.41

673

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

291

1.19

0.43

1.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

291

1.19

0.43

1.2

1.4

—

(3020491) Glucose [Moles/volume] in Blood

559

0.87

0.43

1.3

1.9

6.10

6.86

mmol/l

2.84

377

(3028192) IgG subclass 2 [Mass/volume] in Serum

914

0.90

0.43

1.2

1.4

2.75

2.89

g/l

0.39

670

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

147

1.27

0.42

2.1

1.7

—

(40762887) Creatinine [Moles/volume] in Blood

1.41

0.42

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

377

0.84

0.42

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

1.39

0.41

1.0

1.3

—

17.79

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

106

1.32

0.41

1.1

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

193

0.77

0.41

1.0

1.2

88.21

55.00

u/ml

0.80

188

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

1.54

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.41

0.0

1.0

—

1.45

—

(3000034) Microalbumin [Mass/volume] in Urine

754

0.89

0.41

2.3

2.8

21.75

36.46

mg/l

0.53

501

(3034860) Kappa light chains.free [Mass/volume] in Serum

303

2686

1.06

0.41

3.0

1.5

50.56

37.92

mg/l

0.88

254

2269

(3030981) Hyaline casts [#/volume] in Urine by Automated count

707

6835

0.96

0.41

2.2

2.3

0.49

0.44

e6/l

0.29

679

6444

(3045177) Copper [Moles/volume] in Urine

0.00

0.41

0.0

1.0

—

0.16

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

1.39

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

398

1.15

0.40

1.1

1.2

57.00

58.54

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

461

1.14

0.39

1.8

2.0

0.90

2.48

u/field

2.57

300

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

662

0.89

0.39

1.4

—

8826.67

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.39

0.0

1.1

—

3769.00

—

(3034614) HLA Ag [Interpretation]

0.00

0.39

0.0

1.1

—

(40757373) Influenza virus identified in Isolate

124

1.28

0.39

1.2

1.5

—

(4268621) Lupus anticoagulant assay

835

1.10

0.38

2.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

887

0.91

0.38

1.6

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

303

0.83

0.38

1.2

1.1

109.91

114.63

0.41

268

(3050794) Legionella sp Ab [Presence] in Serum

1.32

0.37

1.0

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

251

0.82

0.37

2.2

1.4

53.86

52.80

0.04

215

(3039000) Anion gap in Blood by calculation

168

1469

1.07

0.37

4.8

5.6

10.25

11.14

mmol/l

3.76

154

1315

(3012565) Volume of 24 hour Urine

367

1.15

0.36

1.9

1.6

2047.71

1897.42

0.44

327

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

557

5029

1.04

0.36

1.1

1.04

1.49

u/ml

—

(3016038) Potassium [Moles/volume] in Urine

704

1.10

0.36

1.3

1.1

37.50

32.16

mmol/l

1.71

580

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

158

0.77

0.36

1.2

1.1

115.08

111.91

0.14

152

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

3001

1.05

0.36

1.9

1.4

9.76

9.91

g/l

0.27

289

2580

(3018572) Chloride [Moles/volume] in Blood

168

1470

1.07

0.36

4.9

5.6

105.26

104.46

mmol/l

1.48

155

1316

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

391

0.86

0.36

2.5

2.0

318.70

122.87

umol/l

1.12

209

(3019309) Folate [Moles/volume] in Red Blood Cells

1783

16376

1.02

0.36

1.8

1.7

1136.66

1192.87

nmol/l

1.63

1288

12276

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

7226

67214

1.02

0.36

4.6

4.8

13.91

12.65

mm/h

11.12

6665

62788

(3035350) Ketones [Presence] in Urine by Test strip

5155

48593

0.98

0.36

4.4

2.56

3.08

estimate

0.10

1054

9850

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

237

1.18

0.35

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.35

1.0

—

(44806071) Cardiolipin IgM antibody measurement

114

0.74

0.35

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

160

1.23

0.35

1.5

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

122

1057

1.08

0.35

1.1

1.51

1.48

g/l

0.53

113

948

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

841

1.09

0.35

1.5

1.6

20.53

23.46

u/ml

0.30

178

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

218

0.81

0.34

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

763

0.91

0.34

1.5

1.6

88.92

90.71

ng/l

0.08

763

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

704

0.90

0.34

1.0

1.1

5.80

8.10

iu/ml

0.66

147

(3015076) Soybean IgE Ab [Units/volume] in Serum

398

0.87

0.34

1.0

0.18

0.30

u/ml

—

(3002619) Bacteria identified in Specimen by Culture

230

1.18

0.33

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

477

0.88

0.33

1.0

0.62

0.93

u/ml

0.37

112

(3023419) Bacteria identified in Sputum by Culture

115

996

1.08

0.33

2.8

2.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

737

6702

1.03

0.33

2.4

2.5

24.85

24.09

au/ml

0.09

706

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

227

0.82

0.33

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

136

1.24

0.32

1.0

92.99

78.92

ug/l

1.23

102

(3005011) Chlamydia sp Ab [Titer] in Serum

124

0.75

0.32

1.9

1.7

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.66

0.32

1.8

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

574

0.90

0.32

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

282

2518

1.05

0.32

1.2

148.46

148.97

titre

0.00

224

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

205

1.19

0.32

1.0

1.1

920.00

1093.02

titre

—

(4146454) Self-monitoring of blood glucose

115

999

1.08

0.32

2.4

2.7

—

(3023410) Appearance of Cerebral spinal fluid

100

864

1.08

0.31

1.6

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

837

1.08

0.31

1.5

1.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.36

0.31

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

719

0.91

0.31

1.5

1.7

7.38

6.80

umol/l

0.12

521

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

346

1.14

0.31

6.0

4.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.34

0.31

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.73

0.31

1.1

2.9

—

(3024263) Appearance of Synovial fluid

444

1.12

0.31

1.8

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

174

0.81

0.30

1.1

—

13.20

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

510

4923

0.97

0.30

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

194

0.82

0.30

1.2

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

244

0.84

0.30

1.0

3.32

8.97

u/ml

2.01

149

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

647

0.91

0.29

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.28

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

130

1.22

0.28

7.9

6.4

72.64

70.32

0.12

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

145

1438

0.94

0.28

1.6

14.04

18.87

u/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

217

1.16

0.28

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

394

1.12

0.28

1.7

1.9

—

(4094501) Cardiovascular stress test using bicycle ergometer

262

2555

0.96

0.27

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

109

0.77

0.27

1.6

2.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

404

1.11

0.27

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

157

1.19

0.27

1.0

1.1

27.98

29.25

iu/ml

0.05

157

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

264

2369

1.04

0.27

2.0

2.2

11.31

11.39

mg/l

0.07

245

2191

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

211

0.84

0.26

1.3

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.29

0.26

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

822

7857

0.98

0.26

2.1

2.0

3.17

3.26

ratio

1.54

635

6030

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

139

1227

1.06

0.26

1.2

2.60

3.61

u/ml

0.60

451

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.69

0.26

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

414

1.11

0.26

2.3

2.1

16.13

15.81

0.41

414

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

545

0.91

0.26

1.1

—

(4195642) Thrombophilia screening test

129

1137

1.06

0.26

1.1

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4495

41745

1.01

0.25

3.0

3.1

118.15

93.89

ug/l

7.37

4114

38652

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

239

0.86

0.24

1.3

38.29

41.35

0.14

165

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

168

1497

1.05

0.24

1.1

10.62

17.55

au/ml

1.60

289

(3000060) B lymphocytes [#/volume] in Blood

133

1.20

0.24

1.4

2.0

0.34

0.15

e9/l

—

(3011985) Renin [Units/volume] in Plasma

156

1388

1.05

0.23

1.4

60.86

53.04

mu/l

0.21

142

1250

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

275

1.12

0.22

1.2

1.3

27.20

22.24

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

849

0.94

0.22

1.2

—

(3020650) Glucose [Presence] in Urine

286

0.88

0.22

2.1

1.9

0.00

0.03

estimate

1.23

286

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.74

0.22

1.9

1.09

1.67

mg/l

—

(3045414) Leukocytes [Presence] in Urine

1022

9716

0.98

0.22

2.2

2.1

0.03

0.01

estimate

0.25

143

1888

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.26

0.22

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2664

25140

0.99

0.22

3.8

3.7

1.07

0.35

estimate

0.73

814

7504

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.20

0.21

1.8

2.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

373

0.90

0.21

1.0

1.1

—

0.15

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

101

891

1.06

0.21

1.9

1.5

139767.86

128726.65

e6/l

0.05

583

(44806420) Estimation of glomerular filtration rate

120

1065

1.05

0.21

2.1

2.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

6.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

2.02

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

27.18

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

257

2486

0.97

0.21

1.1

6.44

9.08

eliau/ml

0.49

266

(3010375) cycloSPORINE [Mass/volume] in Blood

215

1.13

0.20

25.3

29.2

103.38

106.22

ug/l

0.08

173

(3015736) pH of Urine

4145

38519

1.01

0.20

3.8

3.9

6.28

6.29

0.13

2225

21153

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.20

0.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

517

0.92

0.20

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

164

1599

0.96

0.20

1.2

8.00

13.11

u/ml

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.25

0.20

1.3

1.7

83.50

50.75

umol/l

—

(3032057) Clostridioides difficile [Presence] in Stool

189

1.14

0.19

2.3

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

202

1959

0.96

0.19

1.4

2078.33

1408.81

e6/l

0.20

144

1573

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

245

2367

0.97

0.19

1.1

1.2

4.63

3.81

0.58

267

(3038071) Oxygen [Partial pressure] in Mixed venous blood

119

1.18

0.19

8.7

6.9

7.96

5.39

kpa

0.85

119

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

418

3815

1.03

0.19

2.0

2.1

41.22

40.30

u/l

0.44

365

3384

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.15

0.19

1.7

332.20

594.19

nmol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

114

0.82

0.19

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

132

1181

1.05

0.18

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

203

1965

0.97

0.18

1.2

1.3

3.54

3.74

mmol/l

1.92

193

1869

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.23

0.18

12.8

3.93

4.51

mmol/l

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.11

0.17

1.1

1.3

2.90

4.56

nmol/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

202

1828

1.03

0.17

1.7

1.8

299.91

324.10

mu/l

0.59

191

1627

(3051101) Glucose [Moles/volume] in Cord blood

162

0.87

0.17

4.1

5.5

8.93

8.08

mmol/l

0.69

162

(3006571) Granulocytes/Leukocytes in Synovial fluid

123

1200

0.96

0.16

1.7

1.6

56.73

55.10

0.19

722

(40759836) Histone Ab [Presence] in Serum by Immunoblot

885

0.95

0.16

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

572

1.06

0.16

1.1

245.07

247.37

mg/l

0.02

512

(3043238) Trisomy 21 risk [Likelihood] in Fetus

750

0.95

0.16

1.4

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

433

0.93

0.16

1.2

0.52

0.61

ratio

1.46

270

(3030313) Adrenal Ab [Titer] in Serum

0.76

0.15

1.0

1.1

—

15.20

—

(4211845) Urine protein measurement

455

1.07

0.15

4.0

3.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

239

0.90

0.15

1.0

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

5103

47912

0.99

0.15

4.3

4.4

0.00

estimate

0.48

1010

9405

(37021550) Renin [Units/volume] in Plasma --upright

175

1.12

0.15

1.0

1.3

169.18

59.86

mu/l

0.59

125

(3052592) Norovirus Ag [Presence] in Stool

141

0.86

0.15

1.2

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

383

3656

0.98

0.15

1.4

1.6

9.14

16.73

iu/ml

—

(3014271) Vancomycin [Susceptibility]

429

1.07

0.14

3.1

3.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

575

1.06

0.14

1.0

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

823

0.95

0.14

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

421

1.07

0.14

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

231

1.09

0.13

1.1

4.46

10.05

pmol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

362

0.93

0.13

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

132

1193

1.04

0.13

1.2

3.47

3.48

u/ml

0.01

511

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

868

0.96

0.13

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

377

1.07

0.12

1.5

16.91

15.47

pmol/l

1.03

312

(3045683) HLA typing for celiac disease panel - Blood or Tissue

524

0.95

0.12

1.1

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

867

0.96

0.12

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

614

5821

0.99

0.12

1.8

1.7

3.56

3.54

mmol/l

0.16

415

4024

(3028433) Virus identified in Specimen by Culture

223

1.09

0.12

1.2

1.1

—

(4015189) Microbial culture of sputum

223

1.09

0.12

1.7

2.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

763

7049

1.01

0.12

2.8

3.0

188.08

184.29

ng/l

0.09

706

6462

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

485

0.94

0.12

1.1

2.68

6.82

u/ml

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

275

2518

1.02

0.12

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

106

1027

0.96

0.12

1.2

—

(3005033) Fetal Nuchal fold Thickness US

713

0.96

0.11

1.4

1.25

1.26

0.10

480

(3009261) Glucose [Presence] in Urine by Test strip

5219

48954

0.99

0.11

4.4

0.98

0.14

estimate

0.41

1030

9422

(3000570) Elastase.pancreatic [Mass/mass] in Stool

305

2907

0.98

0.11

1.4

278.27

294.44

ug/g

0.71

176

1639

(3047007) Chlamydophila sp Ab [Presence] in Serum

143

1299

1.03

0.11

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

206

1.09

0.11

1.0

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

397

0.94

0.11

12.2

14.1

0.61

0.64

mmol/l

0.35

359

(3047352) Trisomy 18 risk [Likelihood] in Fetus

721

0.96

0.11

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

578

0.95

0.11

1.1

1.0

2.84

6.96

nmol/l

—

100

(3045716) Anion gap in Serum or Plasma by calculation

858

1.04

0.10

3.3

2.5

10.65

10.54

mmol/l

0.10

848

(42529406) Shigella sp [Presence] in Stool by Culture

275

2524

1.02

0.10

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

185

1690

1.02

0.10

2.0

1.9

3715.65

4412.47

u/l

0.14

687

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

189

1.09

0.10

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

319

0.94

0.10

2.0

3.2

26.59

27.37

umol/l

0.14

248

(3041672) Baker's yeast Ab [Presence] in Serum

1.14

0.10

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

272

2499

1.02

0.09

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.09

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

318

0.94

0.09

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

1.04

0.09

4.2

1.9

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.04

0.09

1.6

1.4

4.53

3.63

mg/l

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.04

0.09

1.0

—

19.13

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.04

0.09

1.0

—

19.36

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2312

21518

1.01

0.09

2.5

2.1

317.09

319.38

umol/l

0.51

2001

18549

(3022493) Free Hemoglobin [Mass/volume] in Plasma

291

1.06

0.09

1.1

3.6

7004.29

67.83

mg/l

0.48

190

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

203

1935

0.98

0.09

1.4

85.44

31.44

e6/l

0.41

127

1466

(3007164) IgA [Mass/volume] in Serum or Plasma

1966

18292

1.01

0.08

1.5

1.4

2.24

2.34

g/l

1.43

1064

10576

(3006462) Nitrate [Presence] in Urine

420

1.05

0.08

3.8

3.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

192

1830

0.98

0.08

3.8

3.7

26.18

23.12

mg/l

0.60

134

1293

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.81

0.08

1.0

1.1

9.40

12.31

u/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

125

0.90

0.08

2.1

2.7

0.83

0.80

u/field

0.06

125

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

347

1.05

0.08

1.2

1.1

266.56

176.90

iu/ml

0.42

342

(3003327) Ova and parasites identified in Stool by Light microscopy

369

3408

1.01

0.08

1.6

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.04

0.08

1.3

1.5

0.44

0.47

e9/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

140

1281

1.02

0.08

1.1

2.31

2.65

0.16

175

(3011897) Casein IgE Ab [Units/volume] in Serum

137

1.09

0.07

1.3

1.1

0.05

0.52

u/ml

0.60

137

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.81

0.07

2.3

2.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

458

0.96

0.07

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

119

1.10

0.07

1.0

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

121

1157

0.98

0.07

1.3

1.2

30.00

48.65

u/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

258

2380

1.01

0.07

1.6

13.50

20.43

iu/ml

—

(3044290) Cell count panel - Cerebral spinal fluid

197

1813

1.02

0.07

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

835

0.97

0.07

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

506

1.04

0.06

1.5

1.6

78.39

73.74

umol/l

0.25

506

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

900

0.98

0.06

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

711

0.97

0.06

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

111

1.10

0.06

1.0

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2453

23010

1.00

0.06

4.1

4.3

0.29

0.19

0.33

270

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

753

7087

0.99

0.06

1.2

138.75

144.23

u/ml

0.15

267

2821

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

332

0.96

0.06

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.11

0.05

1.6

1.4

11.11

10.60

pmol/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

425

1.03

0.05

1.2

125.86

144.38

mmol/24h

1.10

425

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

170

0.93

0.05

1.6

2.5

6.36

7.16

mmol/l

—

108

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

453

1.03

0.05

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

259

1.05

0.05

1.0

1.1

89.50

93.18

0.22

119

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

250

1.05

0.05

1.0

1.1

97.36

95.53

0.08

117

(3044941) Cell count panel - Synovial fluid

184

1743

0.99

0.05

1.6

1.5

—

(3033099) Centromere Ab [Titer] in Serum

278

1.04

0.05

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

311

0.96

0.04

1.5

1.1

39.94

39.69

g/l

0.09

311

(3024471) HLA-A [Type]

131

1.07

0.04

1.0

—

(3034770) Mitochondria Ab [Titer] in Serum

274

2540

1.01

0.04

1.2

831.25

980.60

titre

—

117

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

253

0.96

0.03

1.2

1.4

107.58

133.56

nmol/l

0.40

167

(3000475) Leukocytes [#/volume] in Synovial fluid

269

2496

1.01

0.03

1.8

1.7

12677.87

11918.19

e6/l

0.11

193

1751

(3027273) Bicarbonate [Moles/volume] in Venous blood

394

3662

1.01

0.03

3.0

3.1

25.54

25.71

mmol/l

0.48

384

3556

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

126

1164

1.01

0.03

1.2

1.1

4.13

4.09

eliau/ml

0.01

488

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

318

0.97

0.03

1.1

99.32

95.38

0.30

239

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

802

1.01

0.02

1.3

0.70

1.18

u/ml

0.51

458

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

214

0.96

0.02

1.0

1.2

274.18

309.73

pmol/l

0.21

146

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4512

42226

1.00

0.02

2.2

100.52

100.23

pmol/l

0.13

2065

19787

(4133840) Spirometry

157

0.95

0.02

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

319

2996

1.00

0.02

1.6

1.7

3.26

4.00

mg/l

0.99

239

2248

(3034426) Prothrombin time (PT)

231

0.97

0.01

1.1

26.33

27.94

1.21

231

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

236

2216

1.00

0.01

1.3

555.08

504.15

mg/l

0.57

226

2111

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

327

3049

1.00

0.01

1.9

2.0

3.94

14.27

iu/l

0.89

121

1267

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

446

4162

1.00

0.01

3.5

3.7

46.65

47.06

0.13

440

4116

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

144

1.04

0.00

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

224

2089

1.00

0.00

1.2

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

107

1.05

0.00

1.1

1.2

—

(3024932) HLA-DR beta [Type]

128

1.02

0.00

1.1

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

106

0.97

0.00

3.0

2.9

—

27.98

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

110

1.02

0.00

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

180

0.99

0.00

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

535

1.00

0.00

1.3

1.4

4.49

5.44

u/l

1.77

456

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

359

0.99

0.00

1.1

75.78

527.57

ng/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

409

1.01

0.00

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

220

0.98

0.00

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

212

1.01

0.00

1.0

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

667

1.00

0.00

1.1

1.0

314.20

298.56

mg/l

1.02

597

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

598

1.00

0.00

1.1

1.2

33.08

40.05

mg/l

0.91

510

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

183

1.02

0.00

1.2

1.4

1.17

1.19

mmol/l

0.41

183

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

435

1.01

0.00

1.8

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

174

1632

1.00

0.00

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.98

0.00

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

177

1.00

0.00

1.3

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

118

1.03

0.00

1.1

1.2

54.92

64.11

ug/l

2.06

118

(3045424) Erythrocytes [Presence] in Urine

493

4613

1.00

0.00

2.2

2.1

2.29

0.01

estimate

0.50

110

1536

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

173

0.97

0.00

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

210

0.98

0.00

1.0

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

1.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

17.17

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

33.11

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.98

-0.00

1.0

32.50

48.40

u/l

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

175.00

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.97

-0.00

1.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.98

-0.00

1.1

1.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

27.44

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.91

-0.00

1.3

1.1

148.00

86.24

titre

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.88

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.98

-0.00

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.98

-0.00

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.94

-0.00

4.6

6.9

11.18

10.12

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BREAST_ERNEG_WIDE – Malignant neoplasm of breast, ER-negative, including Hilmo

GWS hits: 20

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of breast, ER-negative, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of breast, ER-negative, including Hilmo (C3_BREAST_ERNEG_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints